3,770 results on '"Liebeskind, David S"'
Search Results
202. Recanalization and Clinical Outcome of Occlusion Sites at Baseline CT Angiography in the Interventional Management of Stroke III Trial
- Author
-
Demchuk, Andrew M, Goyal, Mayank, Yeatts, Sharon D, Carrozzella, Janice, Foster, Lydia D, Qazi, Emmad, Hill, Michael D, Jovin, Tudor G, Ribo, Marc, Yan, Bernard, Zaidat, Osama O, Frei, Donald, von Kummer, Rüdiger, Cockroft, Kevin M, Khatri, Pooja, Liebeskind, David S, Tomsick, Thomas A, Palesch, Yuko Y, Broderick, Joseph P, and Investigators, For the I III
- Subjects
Brain Disorders ,Stroke ,Clinical Research ,Biomedical Imaging ,Neurosciences ,Adult ,Aged ,Aged ,80 and over ,Cerebral Angiography ,Endovascular Procedures ,Female ,Fibrinolytic Agents ,Humans ,Magnetic Resonance Angiography ,Male ,Middle Aged ,Tissue Plasminogen Activator ,Tomography ,X-Ray Computed ,Treatment Outcome ,IMS III Investigators ,Medical and Health Sciences ,Nuclear Medicine & Medical Imaging - Abstract
PurposeTo use baseline computed tomographic (CT) angiography to analyze imaging and clinical end points in an Interventional Management of Stroke III cohort to identify patients who would benefit from endovascular stroke therapy.Materials and methodsThe primary clinical end point was 90-day dichotomized modified Rankin Scale (mRS) score. Secondary end points were 90-day mRS score distribution and 24-hour recanalization. Prespecified subgroup was baseline proximal occlusions (internal carotid, M1, or basilar arteries). Exploratory analyses were subsets with any occlusion and specific sites of occlusion (two-sided α = .01).ResultsOf 656 subjects, 306 (47%) underwent baseline CT angiography or magnetic resonance angiography. Of 306, 282 (92%) had arterial occlusions. At baseline CT angiography, proximal occlusions (n = 220) demonstrated no difference in primary outcome (41.3% [62 of 150] endovascular vs 38% [27 of 70] intravenous [IV] tissue-plasminogen activator [tPA]; relative risk, 1.07 [99% confidence interval: 0.67, 1.70]; P = .70); however, 24-hour recanalization rate was higher for endovascular treatment (n = 167; 84.3% [97 of 115] endovascular vs 56% [29 of 52] IV tPA; P < .001). Exploratory subgroup analysis for any occlusion at baseline CT angiography did not demonstrate significant differences between endovascular and IV tPA arms for primary outcome (44.7% [85 of 190] vs 38% [35 of 92], P = .29), although ordinal shift analysis of full mRS distribution demonstrated a trend toward more favorable outcome (P = .011). Carotid T- or L-type occlusion (terminal internal carotid artery [ICA] with M1 middle cerebral artery and/or A1 anterior cerebral artery involvement) or tandem (extracranial or intracranial) ICA and M1 occlusion subgroup also showed a trend favoring endovascular treatment over IV tPA alone for primary outcome (26% [12 of 46] vs 4% [one of 23], P = .047).ConclusionSignificant differences were identified between treatment arms for 24-hour recanalization in proximal occlusions; carotid T- or L-type and tandem ICA and M1 occlusions showed greater recanalization and a trend toward better outcome with endovascular treatment. Vascular imaging should be mandated in future endovascular trials to identify such occlusions. Online supplemental material is available for this article.
- Published
- 2014
203. New Microbleeds After Thrombolysis
- Author
-
Yan, Shenqiang, Chen, Yi, Zhang, Xuting, Liebeskind, David S, and Lou, Min
- Subjects
Hematology ,Clinical Research ,Stroke ,Neurosciences ,Brain Disorders ,Adult ,Aged ,Aged ,80 and over ,Blood Pressure ,Brain Ischemia ,Female ,Humans ,Intracranial Hemorrhages ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Regression Analysis ,Retrospective Studies ,Risk Factors ,Thrombolytic Therapy ,Treatment Outcome ,Clinical Sciences ,Arthritis & Rheumatology - Abstract
We aimed to determine the frequency of new microbleeds after intravenous thrombolysis using contiguous thin-slice 3T magnetic resonance imaging. We retrospectively examined clinical and imaging data from 121 consecutive acute ischemic stroke patients who underwent magnetic resonance imaging before and 24 hours after intravenous thrombolysis. Of the included patients, 44 (36.4%) were women, with a median age of 69 years (range, 35-94 years). A total of 363 baseline microbleeds were observed in 57 patients and 8 new microbleeds in 6 patients. Multiple regression analysis indicated that baseline infarct volume (odds ratio, 1.556/10 mL; 95% CI, 1.017-2.379; P = 0.04) and systolic blood pressure (odds ratio, 1.956/10 mm Hg; 95% CI, 1.056-3.622; P = 0.03), but not the presence of baseline microbleeds, were independently associated with new microbleeds. The frequency of neither symptomatic intracranial hemorrhage nor remote hemorrhage or any hemorrhagic transformation was different between patients with and without new microbleeds (0.0% vs 1.7%, P > 0.99; 0.0% vs 1.7%, P > 0.99; 50.0% vs 28.7%, P =0.36). New microbleeds developed rapidly 24 hours after intravenous thrombolysis. The significance of these new microbleeds and their effect on cognitive and functional outcome merits further investigation.
- Published
- 2014
204. Association of ischemic stroke, hormone therapy, and right to left shunt in postmenopausal women
- Author
-
Greep, Nancy C, Liebeskind, David S, Gevorgyan, Rubine, Truong, Tam, Cua, Bennett, Tseng, Chi‐Hong, Dodick, David W, Demaerschalk, Bart M, Thaler, David E, and Tobis, Jonathan M
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Neurosciences ,Estrogen ,Clinical Research ,Aging ,Stroke ,Brain Disorders ,Aged ,Brain Ischemia ,Cardiac Catheterization ,Echocardiography ,Female ,Foramen Ovale ,Patent ,Hormone Replacement Therapy ,Humans ,Middle Aged ,Prevalence ,Risk Factors ,Treatment Outcome ,Ultrasonography ,Doppler ,Transcranial ,United States ,cryptogenic stroke ,hormone therapy ,patent foramen ovale ,Cryptogenic stroke ,Hormone therapy ,Patent foramen ovale ,Cardiorespiratory Medicine and Haematology ,Cardiovascular System & Hematology ,Cardiovascular medicine and haematology - Abstract
BackgroundPostmenopausal hormone therapy (HT) increases the risk of venous thrombosis and ischemic stroke.ObjectivesWe postulated that HT might increase the risk of ischemic stroke by promoting venous clots that travel to the brain through a right to left shunt (RLS).MethodsA total of 2,389 records were studied. After eliminating the premenopausal patients, and those with TIAs and non-ischemic strokes, the medical records of 1846 postmenopausal women hospitalized at four institutions for ischemic stroke were reviewed to identify those who had undergone an adequate study to assess for RLS. The proportion of women with a shunt in users and non-users of HT was compared in stroke patients and in a reference population consisting of postmenopausal women undergoing elective cardiac catheterization.ResultsThere were 363 (20%) records that had complete data and were included in the analysis. A shunt was more prevalent in patients with a cryptogenic stroke than in patients with a stroke of known cause (55/88 (63%) vs. 53/275 (19%), P
- Published
- 2014
205. Research
- Author
-
Shi, Zhenghao, Zhang, Xuting, Chen, Zhicai, Liebeskind, David S, and Lou, Min
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Trials and Supportive Activities ,Clinical Research ,Cardiovascular ,Brain Disorders ,Autoimmune Disease ,Heart Disease ,Stroke ,Adult ,Age of Onset ,Autoantibodies ,Brain ,Brain Ischemia ,Child ,Constriction ,Pathologic ,Female ,Humans ,Male ,Middle Aged ,Prospective Studies ,Registries ,Retrospective Studies ,Risk Factors ,Thyroid Function Tests ,Thyroid Gland ,Young Adult ,age ,antithyroperoxidase antibody ,stenosis ,stroke ,thyroid ,Age ,Antithyroperoxidase antibody ,Stenosis ,Thyroid ,Neurosciences ,Neurology & Neurosurgery ,Clinical sciences ,Allied health and rehabilitation science - Abstract
BackgroundPrevious studies have shown that hyperthyroidism was related to Moyamoya disease and intracranial artery stenosis. However, it is not clear whether thyroid hormone or thyroid autoantibodies was associated with them.Aims and/or hypothesisThyroid autoimmunity was previously shown to be associated with Moyamoya disease. Our study aimed to investigate the association between thyroid autoantibodies and intracranial large artery stenosis in young ischemic stroke patients with apparent euthyroid states.MethodsWe retrospectively reviewed first-onset ischemic stroke patients (age ≤55 years old) consecutively admitted to a single academic center. Intracranial large artery stenosis was defined as ≥50% luminal diameter narrowing. We compared demographic profiles, risk factors (age, hypertension, diabetes, current smoker, atrial fibrillation, hyperlipidemia), thyroid function test, and thyroid autoantibodies including antithyroperoxidase antibody and antithyroglobulin antibody between patients with and without intracranial large artery stenosis. We also performed multivariate logistic regression analysis to evaluate the association between thyroid autoantibodies and intracranial large artery stenosis.ResultsA total of 351 patients were analyzed. The mean age of the patients was 47·0 ± 7·7 (range, 10-55 years), and 252 (71·8%) patients were male. We identified intracranial large artery stenosis in 121 (34·5%) patients. Patients with intracranial large artery stenosis showed a higher frequency of elevated antithyroperpxidase antibody levels in comparison with nonintracranial large artery stenosis group (16·5% vs. 3·9%, P
- Published
- 2014
206. Research
- Author
-
Flint, Alexander C, Cullen, Sean P, Rao, Vivek A, Faigeles, Bonnie S, Pereira, Vitor M, Levy, Elad I, Jovin, Tudor G, Liebeskind, David S, Nogueira, Raul G, Jahan, Reza, Saver, Jeffrey L, and trialists, SWIFT and STAR
- Subjects
Patient Safety ,Brain Disorders ,Stroke ,Cardiovascular ,Good Health and Well Being ,Aged ,Brain Ischemia ,Endovascular Procedures ,Female ,Health Status Indicators ,Humans ,Logistic Models ,Male ,Multivariate Analysis ,Neurosurgical Procedures ,Prognosis ,Prospective Studies ,ROC Curve ,Retrospective Studies ,Risk ,Treatment Outcome ,acute ,acute stroke therapy ,cerebral infarction ,ischemic stroke ,reperfusion ,treatment ,SWIFT and STAR trialists ,Clinical Sciences ,Neurosciences ,Neurology & Neurosurgery - Abstract
BackgroundThe Totaled Health Risks in Vascular Events (THRIVE) score strongly predicts clinical outcome, mortality, and risk of thrombolytic haemorrhage in ischemic stroke patients, and performs similarly well in patients receiving intravenous tissue plasminogen activator, endovascular stroke treatment, or no acute treatment. It is not known if the THRIVE score predicts outcomes with the Solitaire endovascular stroke treatment device.AimsTo validate the relationship between the THRIVE score and outcomes after treatment with the Solitaire endovascular stroke treatment device.MethodsThe study conducted a retrospective analysis of the prospective SWIFT and STAR trials to examine the relationship between THRIVE and outcomes after treatment with the Solitaire device. We examined the relationship between THRIVE and clinical outcomes (good outcome or death at 90 days) among patients in SWIFT and STAR. Receiver-operator characteristics curve analysis was used to compare THRIVE score performance with other stroke prediction scores. Multivariable modeling was used to confirm the independence of the THRIVE score from procedure-specific predictors (successful recanalization or device used) and other predictors of functional outcome.ResultsThe THRIVE score strongly predicts good outcome and death among patients treated with the Solitaire device in SWIFT and STAR (Mantel-Haenszel chi-square test for trend P
- Published
- 2014
207. Impact of Collaterals on Successful Revascularization in Solitaire FR With the Intention for Thrombectomy
- Author
-
Liebeskind, David S, Jahan, Reza, Nogueira, Raul G, Zaidat, Osama O, and Saver, Jeffrey L
- Subjects
Neurosciences ,Stroke ,Brain Disorders ,Clinical Research ,Cardiovascular ,Aged ,Aged ,80 and over ,Blood Glucose ,Blood Pressure ,Cerebral Angiography ,Cerebrovascular Circulation ,Collateral Circulation ,Female ,Humans ,Male ,Middle Aged ,Patient Outcome Assessment ,Randomized Controlled Trials as Topic ,Severity of Illness Index ,Single-Blind Method ,Thrombectomy ,collaterals ,endovascular therapy ,stroke ,revascularization ,SWIFT Investigators ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
Background and purposeCollaterals at angiography before endovascular therapy were analyzed to ascertain the effect on a novel end point of successful revascularization without symptomatic hemorrhage in the Solitaire FR With the Intention for Thrombectomy (SWIFT) study.MethodsCollateral grade (American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology) on baseline angiography was independently assessed, blind to other data, with statistical analyses delineating the relationship with clinical, laboratory, and imaging parameters.ResultsAngiographic data on collaterals were available in 119 of 144 subjects (mean age, 67±12 years; 52% woman; median National Institutes of Health Stroke Scale, 18 [range, 8-28]). Worse collaterals were noted in subjects with elevated baseline blood glucose (P=0.013) and those with elevated baseline systolic blood pressure (P=0.039). Multivariate predictors of partial or worse collaterals included absence of prior hypertension (odds ratio, 4.049, P=0.012), smoking history (odds ratio, 3.822; P=0.013), and higher blood glucose (odds ratio, 1.017; P=0.022). Collaterals were strongly related to Alberta Stroke Program Early CT Score (ASPECTS) at baseline (0-1: median 8 [3-10]; 2-9 [5-10]; 3-9 [7-10]; 4-9 [8-10]; P
- Published
- 2014
208. Predictors of Functional Dependence Despite Successful Revascularization in Large-Vessel Occlusion Strokes
- Author
-
Shi, Zhong-Song, Liebeskind, David S, Xiang, Bin, Ge, Sijian Grace, Feng, Lei, Albers, Gregory W, Budzik, Ronald, Devlin, Thomas, Gupta, Rishi, Jansen, Olav, Jovin, Tudor G, Killer-Oberpfalzer, Monika, Lutsep, Helmi L, Macho, Juan, Nogueira, Raul G, Rymer, Marilyn, Smith, Wade S, Wahlgren, Nils, and Duckwiler, Gary R
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Neurosciences ,Clinical Trials and Supportive Activities ,Stroke ,Clinical Research ,Brain Disorders ,Aged ,Aged ,80 and over ,Brain Infarction ,Brain Ischemia ,Cerebral Revascularization ,Clinical Trials as Topic ,Female ,Humans ,Male ,Middle Aged ,Multicenter Studies as Topic ,Predictive Value of Tests ,Recovery of Function ,Severity of Illness Index ,Thrombectomy ,Thrombolytic Therapy ,stroke ,Multi MERCI ,TREVO ,and TREVO 2 Investigators ,Cardiorespiratory Medicine and Haematology ,Neurology & Neurosurgery ,Clinical sciences ,Allied health and rehabilitation science - Abstract
Background and purposeHigh revascularization rates in large-vessel occlusion strokes treated by mechanical thrombectomy are not always associated with good clinical outcomes. We evaluated predictors of functional dependence despite successful revascularization among patients with acute ischemic stroke treated with thrombectomy.MethodsWe analyzed the pooled data from the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI), Thrombectomy Revascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO), and TREVO 2 trials. Successful revascularization was defined as thrombolysis in cerebral infarction score 2b or 3. Functional dependence was defined as a score of 3 to 6 on the modified Rankin Scale at 3 months. We assessed relationship of demographic, clinical, angiographic characteristics, and hemorrhage with functional dependence despite successful revascularization.ResultsTwo hundred and twenty-eight patients with successful revascularization had clinical outcome follow-up. The rates of functional dependence with endovascular success were 48.6% for Trevo thrombectomy and 58.0% for Merci thrombectomy. Age (odds ratio, 1.04; 95% confidence interval, 1.02-1.06 per 1-year increase), National Institutes of Health Stroke Scale score (odds ratio, 1.08; 95% confidence interval, 1.02-1.15 per 1-point increase), and symptom onset to endovascular treatment time (odds ratio, 1.11; 95% confidence interval, 1.01-1.22 per 30-minute delay) were predictors of functional dependence despite successful revascularization. Symptom onset to reperfusion time beyond 5 hours was associated with functional dependence. All subjects with symptomatic intracranial hemorrhage had functional dependence.ConclusionsOne half of patients with successful mechanical thrombectomy do not have good outcomes. Age, severe neurological deficits, and delayed endovascular treatment were associated with functional dependence despite successful revascularization. Our data support efforts to minimize delays to endovascular therapy in patients with acute ischemic stroke to improve outcomes.Clinical trial registration urlhttp://www.clinicaltrials.gov. Unique identifier: NCT00318071, NCT01088672, and NCT01270867.
- Published
- 2014
209. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial
- Author
-
Khatri, Pooja, Yeatts, Sharon D, Mazighi, Mikael, Broderick, Joseph P, Liebeskind, David S, Demchuk, Andrew M, Amarenco, Pierre, Carrozzella, Janice, Spilker, Judith, Foster, Lydia D, Goyal, Mayank, Hill, Michael D, Palesch, Yuko Y, Jauch, Edward C, Haley, E Clarke, Vagal, Achala, Tomsick, Thomas A, and Trialists, for the IMS III
- Subjects
Brain Disorders ,Clinical Research ,Neurosciences ,Stroke ,Cardiovascular ,Adolescent ,Adult ,Aged ,Brain Ischemia ,Carotid Artery Diseases ,Cerebral Angiography ,Endovascular Procedures ,Female ,Fibrinolytic Agents ,Humans ,Infarction ,Middle Cerebral Artery ,Male ,Middle Aged ,Reperfusion ,Time Factors ,Tissue Plasminogen Activator ,Tomography Scanners ,X-Ray Computed ,Treatment Outcome ,Young Adult ,IMS III Trialists ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
BackgroundThe IMS III trial did not show a clinical benefit of endovascular treatment compared with intravenous alteplase (recombinant tissue plasminogen activator) alone for moderate or severe ischaemic strokes. Late reperfusion of tissue that was no longer salvageable could be one explanation, as suggested by previous exploratory studies that showed an association between time to reperfusion and good clinical outcome. We sought to validate this association in a preplanned analysis of data from the IMS III trial.MethodsWe used data for patients with complete proximal arterial occlusions in the anterior circulation who received endovascular treatment and achieved angiographic reperfusion (score on Thrombolysis in Cerebral Infarction scale of grade 2-3) during the endovascular procedure (within 7 h of symptom onset). We used logistic regression to model good clinical outcome (defined as a modified Rankin Scale score of 0-2 at 3 months) as a function of the time to reperfusion. We prespecified variables to be considered for adjustment, including age, baseline National Institutes of Health Stroke Scale score, sex, and baseline blood glucose concentration.FindingsOf 240 patients who were otherwise eligible for inclusion in our analysis, 182 (76%) achieved angiographic reperfusion. Mean time from symptom onset to reperfusion (ie, procedure end) was 325 min (SD 52). Increased time to reperfusion was associated with a decreased likelihood of good clinical outcome (unadjusted relative risk for every 30-min delay 0·85 [95% CI 0·77-0·94]; adjusted relative risk 0·88 [0·80-0·98]).InterpretationDelays in time to angiographic reperfusion lead to a decreased likelihood of good clinical outcome in patients after moderate to severe stroke. Rapid reperfusion could be crucial for the success of future acute endovascular trials.FundingUS National Institutes of Health and National Institute of Neurological Disorders and Stroke.
- Published
- 2014
210. Collateral lessons from recent acute ischemic stroke trials
- Author
-
Liebeskind, David S
- Subjects
Neurosciences ,Brain Disorders ,Clinical Research ,Stroke ,Clinical Trials and Supportive Activities ,Brain ,Brain Ischemia ,Cerebral Angiography ,Cerebrovascular Circulation ,Humans ,Infarction ,Middle Cerebral Artery ,Randomized Controlled Trials as Topic ,Ischemia ,Collateral ,Neuroprotection ,Reperfusion ,Collateral ,Ischemia ,Neuroprotection ,Stroke ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
Numerous acute ischemic stroke trials have recently published detailed results, providing an opportunity to consider the role of collaterals in stroke pathophysiology and their influential effect on patient outcomes. Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS), the largest randomized controlled trial of device therapy to date, tested the potential augmentation of collateral perfusion. SYNTHESIS Expansion, Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE), and Interventional Management of Stroke (IMS) III chronicled the saga of endovascular therapy trialed against medical treatment for acute ischemic stroke. These recent randomized studies, however, largely neglect current device technology available for endovascular therapy as advanced by the TREVO2 and SOLITAIRE™(TM) FR With the Intention For Thrombectomy (SWIFT) studies. Such exhaustive efforts in recent trials have failed to introduce a new treatment for stroke that unequivocally improves patient outcomes. Collateral perfusion is widely recognized to vary across individuals in any population and exerts a dramatic effect on baseline variables including the time course of ischemic injury, stroke severity, imaging findings, and therapeutic opportunities. Similarly, collaterals have been recognized to influence recanalization, reperfusion, hemorrhagic transformation, and subsequent neurological outcomes after stroke. Collateral lessons may be gleaned from these trials, to expand consideration of overall study results and perhaps most importantly, alter ongoing and new trials in development. Detailed analyses of available information on collaterals from these trials demonstrate that collaterals may be more influential than the choice of treatment modality or intervention.
- Published
- 2014
211. Data considerations in ischemic stroke trials
- Author
-
Liebeskind, David S and Feldmann, Edward
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Stroke ,Brain Disorders ,Clinical Trials and Supportive Activities ,Clinical Research ,Brain Ischemia ,Clinical Trials as Topic ,Common Data Elements ,Data Collection ,Humans ,Clinical trials ,Data ,Outcomes ,Treatment ,Precision ,Clinical trials ,Data ,Outcomes ,Stroke ,Treatment ,Neurosciences ,Neurology & Neurosurgery ,Clinical sciences - Abstract
Data drive the analyses of any ischemic stroke trial, culminating in the main results and potential next steps. The distinct purpose of a given trial, advancing a novel treatment or examining routine clinical practice, determines the nature of essential data elements. Information gathering for an effective trial depends on ample data, adequate infrastructure, and properly planned statistical analyses. This review highlights the fact that successful future trials will require appropriate expertise that extends far beyond these basic considerations in order to move from identification of basic risk factors that are associated with outcomes to knowledge of pathophysiology and causation of outcomes. Efficient and productive data collection by local and central sites must be complemented by expert core lab adjudications. Source data archiving, including complete DICOM imaging datasets or biological specimens, are needed to maximize the potential for study interpretation and financial investment. Standard terminology, such as common data elements and definitions, enhance study comparisons. Screening logs attest to generalizability of a study. Real-time data transmission and core lab evaluation will be critical to guide adaptive trial design. Despite the overwhelming focus on the intervention in a particular treatment trial, individual pathophysiology must be considered. Understanding individual subject characteristics is a tenet of the coming era of precision stroke care, where the course of a given patient and eventual outcome is paramount. This will require a new approach to data collection in clinical trials.
- Published
- 2014
212. The future of ischemic stroke: flow from prehospital neuroprotection to definitive reperfusion.
- Author
-
Ip, Hing Lung and Liebeskind, David S
- Subjects
Collaterals ,Imaging ,Ischemia ,Neuroprotection ,Reperfusion ,Stroke - Abstract
Recent advances in ischemic stroke enable a seamless transition of the patient flow from the prehospital setting to definitive reperfusion, without the arbitrary separation of therapeutic phases of ischemia based on time alone. In 2013, the framework to understand and directly address the pathophysiology of cerebral blood flow that determines the timeline or evolution of ischemia in an individual case is given. This continuum of flow and the homeostasis of brain perfusion balanced by collaterals may be captured with serial imaging. Ongoing imaging core laboratory activities permit large-scale measurement of angiographic and tissue biomarkers of ischemia. Prehospital neuroprotection has become a reality and may be combined with revascularization therapies. Recent studies confirm that image-guided thrombolysis may be achieved without restrictive time windows. Baseline imaging patterns may be used to predict response to therapy and serial imaging may discern recanalization and reperfusion. Advanced techniques, such as arterial spin-labeled MRI, may also report hyperperfusion associated with hemorrhagic transformation. Endovascular therapies, including novel stent retriever devices, may augment revascularization and angiographic core laboratories may define optimal reperfusion. Serial evaluation of collaterals and reperfusion may identify definitive reperfusion linked with good clinical outcome rather than imposing arbitrary definitions of effective recanalization. Reperfusion injury and hemorrhagic transformation of various types may be detailed to explain clinical outcomes. Similar approaches may be used in intracranial atherosclerosis where flow, and not the degree of luminal stenosis, is paramount. Fractional flow may now be measured with computational fluid dynamics to identify high-risk lesions that require revascularization to restore the equilibrium of antegrade and collateral perfusion. Serial perfusion imaging of such cases may also illustrate inadequate cerebral blood volume gradients that may be more informative than blood flow delay alone. In sum, the growing understanding of collateral perfusion throughout all stages of ischemic stroke provides a framework for the future of ischemic stroke.
- Published
- 2014
213. Collaterals at Angiography and Outcomes in the Interventional Management of Stroke (IMS) III Trial
- Author
-
Liebeskind, David S, Tomsick, Thomas A, Foster, Lydia D, Yeatts, Sharon D, Carrozzella, Janice, Demchuk, Andrew M, Jovin, Tudor G, Khatri, Pooja, von Kummer, Ruediger, Sugg, Rebecca M, Zaidat, Osama O, Hussain, Syed I, Goyal, Mayank, Menon, Bijoy K, Al Ali, Firas, Yan, Bernard, Palesch, Yuko Y, and Broderick, Joseph P
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Neurosciences ,Cerebrovascular ,Clinical Research ,Brain Disorders ,Stroke ,Biomedical Imaging ,Clinical Trials and Supportive Activities ,Adult ,Aged ,Aged ,80 and over ,Blood Pressure ,Cerebral Angiography ,Collateral Circulation ,Comorbidity ,Diabetes Complications ,Endovascular Procedures ,Female ,Fibrinolytic Agents ,Humans ,Male ,Middle Aged ,Multivariate Analysis ,Reperfusion Injury ,Thrombolytic Therapy ,Tissue Plasminogen Activator ,Treatment Outcome ,Young Adult ,angiography ,collateral circulation ,reperfusion ,stroke ,IMS III Investigators ,Cardiorespiratory Medicine and Haematology ,Neurology & Neurosurgery ,Clinical sciences ,Allied health and rehabilitation science - Abstract
Background and purposeEndovascular strategies provide unique opportunity to correlate angiographic measures of collateral circulation at the time of endovascular therapy. We conducted systematic analyses of collaterals at conventional angiography on recanalization, reperfusion, and clinical outcomes in the endovascular treatment arm of the Interventional Management of Stroke (IMS) III trial.MethodsProspective evaluation of angiographic collaterals was conducted via central review of subjects treated with endovascular therapy in IMS III (n=331). Collateral grade before endovascular therapy was assessed with the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology scale, blinded to all other data. Statistical analyses investigated the association between collaterals with baseline clinical variables, angiographic measures of recanalization, reperfusion and clinical outcomes.ResultsAdequate views of collateral circulation to the ischemic territory were available in 276 of 331 (83%) subjects. Collateral grade was strongly related to both recanalization of the occluded arterial segment (P=0.0016) and downstream reperfusion (P
- Published
- 2014
214. Serial Alberta Stroke Program Early CT Score From Baseline to 24 Hours in Solitaire Flow Restoration With the Intention for Thrombectomy Study
- Author
-
Liebeskind, David S, Jahan, Reza, Nogueira, Raul G, Jovin, Tudor G, Lutsep, Helmi L, and Saver, Jeffrey L
- Subjects
Brain Disorders ,Stroke ,Clinical Research ,Aged ,Alberta ,Cerebral Angiography ,Cerebral Revascularization ,Early Diagnosis ,Endpoint Determination ,Female ,Humans ,Infarction ,Middle Cerebral Artery ,Magnetic Resonance Angiography ,Magnetic Resonance Imaging ,Male ,Multivariate Analysis ,Thrombectomy ,Thrombolytic Therapy ,Tomography ,X-Ray Computed ,stroke ,SWIFT Investigators ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Neurosciences ,Neurology & Neurosurgery - Abstract
Background and purposeThe Alberta Stroke Program Early CT Score (ASPECTS) on baseline imaging is an established predictor of acute ischemic stroke outcomes. We analyzed change on serial ASPECTS at baseline and 24-hour imaging in the Solitaire Flow Restoration with the Intention for Thrombectomy (SWIFT) study to determine prognostic value and to identify subgroups with extensive injury after intervention.MethodsASPECTS at baseline and 24 hours was independently scored in all anterior circulation SWIFT cases, blinded to all other trial data. ASPECTS at baseline, at 24 hours, and serial changes were analyzed with univariate and multivariate approaches.ResultsOne hundred thirty-nine patients (mean age, 67 [SD, 12] years; 52% women; median National Institutes of Health Stroke Scale, 18 [interquartile range, 8-28]) with complete data at both time points were studied. Multivariate analyses showed that higher 24-hour ASPECTS predicted good clinical outcome (day 90 modified Rankin Scale, 0-2; odds ratio, 1.67; P
- Published
- 2014
215. Imaging of Cerebral Ischemia From Acute Stroke to Chronic Disorders
- Author
-
Nour, May and Liebeskind, David S
- Subjects
Stroke ,Biomedical Imaging ,Neurosciences ,Brain Disorders ,Detection ,screening and diagnosis ,4.1 Discovery and preclinical testing of markers and technologies ,Neurological ,Brain ,Brain Ischemia ,Chronic Disease ,Humans ,Neuroimaging ,Ischemia ,MRI ,CT ,Collaterals ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
Cerebral ischemia manifests widely in patient symptoms. Along with the clinical examination, imaging serves as a powerful tool throughout the course of ischemia-from acute onset to evolution. A thorough understanding of imaging modalities, their strengths and their limitations, is essential for capitalizing on the benefit of this complementary source of information for understanding the mechanism of disease, making therapeutic decisions, and monitoring patient response over time.
- Published
- 2014
216. Protocol
- Author
-
Saver, Jeffrey L, Starkman, Sidney, Eckstein, Marc, Stratton, Samuel, Pratt, Frank, Hamilton, Scott, Conwit, Robin, Liebeskind, David S, Sung, Gene, Sanossian, Nerses, and Investigators and Coordinators, FAST‐MAG
- Subjects
Neurosciences ,Brain Disorders ,Clinical Trials and Supportive Activities ,Stroke ,Aging ,Clinical Research ,Rehabilitation ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Adult ,Aged ,Aged ,80 and over ,Disability Evaluation ,Double-Blind Method ,Female ,Humans ,Magnesium ,Male ,Middle Aged ,Neurologic Examination ,Treatment Outcome ,ambulance ,clinical trial ,magnesium ,neuroprotection ,paramedic ,prehospital ,FAST-MAG Investigators and Coordinators ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
RationalePrehospital initiation by paramedics may enable delivery of neuroprotective therapies to stroke patients in the hyperacute period when they are most effective in preclinical studies. Magnesium is neuroprotective in experimental stroke models and has been shown to be safe with signals of potential efficacy when started early after onset of human cerebral ischemia.Aims(a) To demonstrate that paramedic initiation of the neuroprotective agent magnesium sulfate in the field is an efficacious and safe treatment for acute stroke; (b) To demonstrate that field enrollment of acute stroke patients is a practical and feasible strategy for phase 3 stroke trials, permitting enrollment of greater numbers of patients in hyperacute time windows.DesignMulticenter, randomized, double-blinded, placebo-controlled, pivotal clinical trial.Study proceduresThe study is enrolling 1700 patients (850 in each arm) with likely acute stroke, including both cerebral infarction and intracerebral hemorrhage patients. Inclusion criteria are: (a) likely stroke as identified by the modified Los Angeles Prehospital Stroke Screen (mLAPSS), (b) age 40-95, (c) symptom onset within 2 h of treatment initiation, and (d) deficit present ≥15 min. Paramedics administer a loading dose of magnesium sulfate (Mg) or matched placebo in the field, 4 grams over 15 min. In the Emergency Department, a maintenance infusion follows, 16 grams Mg or matched placebo over 24 h.OutcomesThe primary endpoint is the modified Rankin Scale measure of global disability, assessed using the Rankin Focused Assessment, 90 days after treatment. Secondary efficacy endpoints include the NIHSS (neurologic deficit), Barthel Index (activities of daily living), and the Stroke Impact Scale (quality of life).
- Published
- 2014
217. Developing Precision Stroke Imaging
- Author
-
Feldmann, Edward and Liebeskind, David S
- Subjects
Clinical Research ,Stroke ,Neurosciences ,Brain Disorders ,Biomedical Imaging ,Good Health and Well Being ,stroke ,neuroimaging ,precision medicine ,Clinical Sciences ,Psychology - Abstract
Stroke experts stand at the cusp of a unique opportunity to advance the care of patients with cerebrovascular disorders across the globe through improved imaging approaches. NIH initiatives including the Stroke Progress Review Group promotion of imaging in stroke research and the newly established NINDS Stroke Trials network converge with the rapidly evolving concept of precision medicine. Precision stroke imaging portends the coming shift to individualized approaches to cerebrovascular disorders where big data may be leveraged to identify and manage stroke risk with specific treatments utilizing an improved neuroimaging infrastructure, data collection, and analysis. We outline key aspects of the stroke imaging field where precision medicine may rapidly transform the care of stroke patients in the next few years.
- Published
- 2014
218. Role of Statin in Atrial Fibrillation-Related Stroke: An Angiographic Study for Collateral Flow
- Author
-
Lee, Mi Ji, Bang, Oh Young, Kim, Suk Jae, Kim, Gyeong Moon, Chung, Chin Sang, Lee, Kwang Ho, Ovbiagele, Bruce, Liebeskind, David S, and Saver, Jeffrey L
- Subjects
Heart Disease ,Clinical Research ,Aging ,Brain Disorders ,Stroke ,Cardiovascular ,Neurosciences ,Adult ,Aged ,Aged ,80 and over ,Atrial Fibrillation ,Brain Ischemia ,Cerebral Angiography ,Collateral Circulation ,Female ,Humans ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Male ,Middle Aged ,Retrospective Studies ,Atrial fibrillation ,Collateral flow ,Statin ,Arteriogenesis ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
BackgroundCurrently, intensive lipid lowering is recommended in patients with atherosclerotic ischemic stroke or transient ischemic attack. However, the role of statin in cardioembolic stroke is unclear. We investigated the association of statin with pretreatment collateral status in cardioembolic stroke.MethodsA collaborative study from two stroke centers in distinct geographic regions included consecutive patients with acute middle cerebral artery (MCA) infarction due to atrial fibrillation (AF) who underwent cerebral angiography. The relationship between pretreatment collateral grade and the use/dose of statin at stroke onset was assessed. The angiographic collateral grade was evaluated according to the ASITN/SIR Collateral Flow Grading System.ResultsNinety-eight patients (76 statin-naïve, 22 statin users) were included. Compared with statin-naïve patients, statin users were older and more frequently had hypertension, hyperlipidemia and coronary heart disease. Excellent collaterals (grade 3-4) were more frequently observed in statin users (11 patients, 50%) than in statin-naïve patients (21 patients, 27.6%; p = 0.049). The use of atorvastatin 10 mg equivalent or higher doses of statin was associated with excellent collaterals (p for trend = 0.025). In multiple regression analysis, prestroke statin use was independently associated with excellent collaterals (odds ratio, 7.841; 95% confidence interval, CI, 1.96-31.363; p = 0.004).ConclusionsPremorbid use of statin in AF patients is associated with excellent collateral flow. Although most statin trials excluded patients with cardioembolic stroke, our data suggests the possibility that statin may be beneficial in AF-related stroke
- Published
- 2014
219. Infarct Patterns, Collaterals and Likely Causative Mechanisms of Stroke in Symptomatic Intracranial Atherosclerosis
- Author
-
López-Cancio, Elena, Matheus, Maria Gisele, Romano, Jose G, Liebeskind, David S, Prabhakaran, Shyam, Turan, Tanya N, Cotsonis, George A, Lynn, Michael J, Rumboldt, Zoran, and Chimowitz, Marc I
- Subjects
Neurosciences ,Stroke ,Brain Disorders ,Clinical Research ,Aging ,Atherosclerosis ,Cardiovascular ,Arteries ,Cerebrovascular Circulation ,Constriction ,Pathologic ,Diffusion Magnetic Resonance Imaging ,Humans ,Intracranial Arteriosclerosis ,Infarct patterns ,Intracranial atherosclerotic stenosis ,Collaterals ,Stenosis location ,Warfarin-Aspirin Symptomatic Intracranial Disease study ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
BackgroundThere are limited data on the specific mechanisms of stroke in patients with intracranial atherosclerotic stenosis (ICAS). We undertook this study to describe infarct patterns and likely mechanisms of stroke in a large cohort of patients with ICAS, and to evaluate the relationship of these infarct patterns to angiographic features (collaterals, stenosis location and stenosis severity).MethodsWe evaluated infarct patterns in the territory of a stenotic intracranial artery on neuroimaging performed at baseline and during follow-up if a recurrent stroke occurred in patients enrolled in the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial. We defined the likely mechanism of stroke (artery-to-artery embolism, perforator occlusion, hypoperfusion or mixed) according to the site of ICAS and based on the infarct patterns on neuroimaging. Collaterals were assessed using American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) grades, and stenosis severity using the WASID trial's measurement technique. We evaluated the association of infarct patterns with angiographic features using χ(2) tests.ResultsThe likely mechanisms of stroke based on the infarct patterns at baseline in the 136 patients included in the study were artery-to-artery embolism (n = 69; 50.7%), perforator occlusion (n = 34; 25%), hypoperfusion (n = 12; 8.8%) and mixed (n = 21; 15.5%). Perforator-occlusive infarcts were more frequent in the posterior circulation, and mixed patterns were more prevalent in the anterior circulation (both p < 0.01). Most of the mixed patterns in the anterior circulation combined small pial or scattered multiple cortical infarcts with infarcts in border-zone regions, especially the cortical ones. Isolated border-zone infarcts were not significantly associated with a poor grading for collaterals or the severity of stenosis. Among 47 patients with a recurrent infarct during follow-up, the infarct patterns suggested an artery-to-artery embolic mechanism in 29 (61.7%).ConclusionsArtery-to-artery embolism is probably the most common mechanism of stroke in both the anterior and the posterior circulations in patients with ICAS. An extension of intracranial atherosclerosis at the site of stenosis into adjacent perforators also appears to be a common mechanism of stroke, particularly in the posterior circulation, whereas hypoperfusion as the sole mechanism is relatively uncommon. Further research is important to accurately establish the specific mechanisms of stroke in patients with ICAS, since preliminary data suggest that the underlying mechanism of stroke is an important determinant of prognosis.
- Published
- 2014
220. Imaging Evaluation of Collaterals in the Brain: Physiology and Clinical Translation
- Author
-
Sheth, Sunil A and Liebeskind, David S
- Subjects
Biomedical Imaging ,Stroke ,Neurosciences ,Brain Disorders ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,screening and diagnosis ,4.2 Evaluation of markers and technologies ,Neurological ,CT ,MRI ,advances in neuro-imaging ,angiography ,collateral ,intracranial stenosis ,moyamoya ,perfusion ,stroke ,thrombectomy - Abstract
The cerebral collateral circulation is a network of blood vessels designed to preserve cerebral blood flow when primary routes fail. Though recognized for hundreds of years, the beneficial influence of collateral flow has now gained significant attention due to widely available, rapid, and real-time non-invasive imaging techniques. Multimodal CT and MRI based techniques, with angiographic and perfusion assessments, are becoming mainstays in the care of patients with ischemic brain disease. These methods allow for precise delineation of the structural and functional aspects of cerebral blood flow and as such provide valuable information that can inform the diagnosis and treatment of cerebral ischemia, in both the acute and chronic setting.
- Published
- 2014
221. To Tube or Not to Tube? The Role of Intubation during Stroke Thrombectomy
- Author
-
Takahashi, Courtney, Liang, Conrad W, Liebeskind, David S, and Hinman, Jason D
- Subjects
Clinical Research ,Brain Disorders ,Stroke ,Neurosciences ,acute stroke ,thrombectomy ,intubation ,endovascular therapy ,clot retrieval ,Clinical Sciences ,Psychology - Abstract
In the 10 years since the FDA first cleared the use of endovascular devices for the treatment of acute stroke, definitive evidence that such therapy improves outcomes remains lacking. The decision to intubate patients undergoing stroke thrombectomy impacts multiple variables that may influence outcomes after stroke. Three main areas where intubation may deleteriously affect acute stroke management include the introduction of delays in revascularization, fluctuations in peri-procedural blood pressure, and hypocapnia, resulting in cerebral vasoconstriction. In this mini-review, we discuss the evidence supporting these limitations of intubation during stroke thrombectomy and encourage neurohospitalists, neurocritical care specialists, and neurointerventionalists to carefully consider the decision to intubate during thrombectomy and provide strategies to avoid potential complications associated with its use in acute stroke.
- Published
- 2014
222. Computational Fluid Dynamics Modeling of Symptomatic Intracranial Atherosclerosis May Predict Risk of Stroke Recurrence
- Author
-
Leng, Xinyi, Scalzo, Fabien, Ip, Hing Lung, Johnson, Mark, Fong, Albert K, Fan, Florence SY, Chen, Xiangyan, Soo, Yannie OY, Miao, Zhongrong, Liu, Liping, Feldmann, Edward, Leung, Thomas WH, Liebeskind, David S, and Wong, Ka Sing
- Subjects
Brain Disorders ,Stroke ,Atherosclerosis ,Clinical Research ,Aged ,Computer Simulation ,Female ,Hemodynamics ,Humans ,Hydrodynamics ,Intracranial Arteriosclerosis ,Male ,Middle Aged ,Models ,Biological ,Recurrence ,Retrospective Studies ,Risk Assessment ,General Science & Technology - Abstract
BackgroundPatients with symptomatic intracranial atherosclerosis (ICAS) of ≥ 70% luminal stenosis are at high risk of stroke recurrence. We aimed to evaluate the relationships between hemodynamics of ICAS revealed by computational fluid dynamics (CFD) models and risk of stroke recurrence in this patient subset.MethodsPatients with a symptomatic ICAS lesion of 70-99% luminal stenosis were screened and enrolled in this study. CFD models were reconstructed based on baseline computed tomographic angiography (CTA) source images, to reveal hemodynamics of the qualifying symptomatic ICAS lesions. Change of pressures across a lesion was represented by the ratio of post- and pre-stenotic pressures. Change of shear strain rates (SSR) across a lesion was represented by the ratio of SSRs at the stenotic throat and proximal normal vessel segment, similar for the change of flow velocities. Patients were followed up for 1 year.ResultsOverall, 32 patients (median age 65; 59.4% males) were recruited. The median pressure, SSR and velocity ratios for the ICAS lesions were 0.40 (-2.46-0.79), 4.5 (2.2-20.6), and 7.4 (5.2-12.5), respectively. SSR ratio (hazard ratio [HR] 1.027; 95% confidence interval [CI], 1.004-1.051; P = 0.023) and velocity ratio (HR 1.029; 95% CI, 1.002-1.056; P = 0.035) were significantly related to recurrent territorial ischemic stroke within 1 year by univariate Cox regression, respectively with the c-statistics of 0.776 (95% CI, 0.594-0.903; P = 0.014) and 0.776 (95% CI, 0.594-0.903; P = 0.002) in receiver operating characteristic analysis.ConclusionsHemodynamics of ICAS on CFD models reconstructed from routinely obtained CTA images may predict subsequent stroke recurrence in patients with a symptomatic ICAS lesion of 70-99% luminal stenosis.
- Published
- 2014
223. Predicting discharge mortality after acute ischemic stroke using balanced data.
- Author
-
Ho, King Chung, Speier, William, El-Saden, Suzie, Liebeskind, David S, Saver, Jeffery L, Bui, Alex AT, and Arnold, Corey W
- Subjects
Humans ,Brain Ischemia ,Patient Discharge ,Models ,Statistical ,Logistic Models ,Bayes Theorem ,Decision Trees ,Artificial Intelligence ,Stroke ,Support Vector Machine ,Brain Disorders ,Good Health and Well Being - Abstract
Several models have been developed to predict stroke outcomes (e.g., stroke mortality, patient dependence, etc.) in recent decades. However, there is little discussion regarding the problem of between-class imbalance in stroke datasets, which leads to prediction bias and decreased performance. In this paper, we demonstrate the use of the Synthetic Minority Over-sampling Technique to overcome such problems. We also compare state of the art machine learning methods and construct a six-variable support vector machine (SVM) model to predict stroke mortality at discharge. Finally, we discuss how the identification of a reduced feature set allowed us to identify additional cases in our research database for validation testing. Our classifier achieved a c-statistic of 0.865 on the cross-validated dataset, demonstrating good classification performance using a reduced set of variables.
- Published
- 2014
224. The impact of collateral therapeutics on stroke hemodynamics in normotensive and hypertensive rats: a step toward translation.
- Author
-
Cipolla, Marilyn J., Hunt, Ryan D., Liebeskind, David S., and Tremble, Sarah M.
- Subjects
STROKE ,CEREBRAL circulation ,HEMODYNAMICS ,COLLATERAL security ,RATS - Abstract
Introduction: Stroke interventions that increase collateral flow have the potential to salvage penumbral tissue and increase the number of patients eligible for reperfusion therapy. We compared the efficacy of two different collateral therapeutics during transient middle cerebral artery occlusion (tMCAO) in normotensive and hypertensive rats. Methods: The change in collateral and core perfusion was measured using dual laser Doppler in response to either a pressor agent (phenylephrine, 10mg/kg iv or vehicle) or a collateral vasodilator (TM5441, 5mg/kg iv or vehicle) given 30min into tMCAO in male Wistar and spontaneously hypertensive rats (SHRs). Results: Pressor therapy increased collateral flow in the Wistar rats but was ineffective in the SHRs. The increase in collateral flow in the Wistar rats was associated with impaired cerebral blood flow autoregulation (CBFAR) that was intact in the SHRs. TM5441 caused a decrease in collateral perfusion in the Wistar rats and a modest increase in the SHRs. The pressor therapy reduced early infarction in both groups but increased edema in the SHRs, whereas TM5441 did not have any beneficial effects in either group. Conclusions: Thus, the pressor therapy was superior to a collateral vasodilator in increasing collateral flow and improving outcomes in the Wistar rats, likely due to pial collaterals that were pressure passive; the lack of CBF response in the SHRs to pressor therapy was likely due to intact CBFAR that limited perfusion. While TM5441 modestly increased CBF in the SHRs but not in the Wistar rats, it did not have a beneficial effect on stroke outcomes. These results suggest that collateral therapies may need to be selected for certain comorbidities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
225. Evaluation of effectiveness and safety of the CorPath GRX robotic system in endovascular embolization procedures of cerebral aneurysms.
- Author
-
Mendes Pereira, Vitor, Rice, Hal, De Villiers, Laetitia, Sourour, Nader, Clarencon, Frédéric, Spears, Julian, Tomasello, Alejandro, Hernandez, David, Cancelliere, Nicole M., Xiao Yu Eileen Liu, Nicholson, Patrick, Costalat, Vincent, Gascou, Gregory, Mordasini, Pasquale, Gralla, Jan, Martínez-Galdámez, Mario, Galvan Fernandez, Jorge, Killer-Oberpfalzer, Monika, Liebeskind, David S., and Turner, Raymond D.
- Subjects
INTRACRANIAL aneurysm surgery ,SURGICAL robots ,INTRACRANIAL aneurysms ,CEREBRAL angiography ,PEARSON correlation (Statistics) ,PATIENT safety ,STATISTICAL significance ,RESEARCH funding ,THERAPEUTIC embolization ,ENDOVASCULAR surgery ,TREATMENT effectiveness ,SURGICAL stents ,DESCRIPTIVE statistics ,LONGITUDINAL method ,RESEARCH ,CONFIDENCE intervals ,DATA analysis software - Abstract
Background Robotic-assisted neurointervention was recently introduced, with implications that it could be used to treat neurovascular diseases. Objective To evaluate the effectiveness and safety of the robotic-assisted platform CorPath GRX for treating cerebral aneurysms. Methods This prospective, international, multicenter study enrolled patients with brain aneurysms that required endovascular coiling and/or stent-assisted coiling. The primary effectiveness endpoint was defined as successful completion of the robotic-assisted endovascular procedure without any unplanned conversion to manual treatment with guidewire or microcatheter navigation, embolization coil(s) or intracranial stent(s) deployment, or an inability to navigate vessel anatomy. The primary safety endpoint included intraprocedural and periprocedural events. Results The study enrolled 117 patients (74.4% female) with mean age of 56.6 years from 10 international sites,. Headache was the most common presenting symptom in 40/117 (34.2%) subjects. Internal carotid artery was the most common location (34/122, 27.9%), and the mean aneurysm height and neck width were 5.7±2.6 mm and 3.5±1.4 mm, respectively. The overall procedure time was 117.3±47.3 min with 59.4±32.6 min robotic procedure time. Primary effectiveness was achieved in 110/117 (94%) subjects with seven subjects requiring conversion to manual for procedure completion. Only four primary safety events were recorded with two intraprocedural aneurysm ruptures and two strokes. A Raymond-Roy Classification Scale score of 1 was achieved in 71/110 (64.5%) subjects, and all subjects were discharged with a modified Rankin Scale score of ≤2. Conclusions This first-of-its-kind robotic-assisted neurovascular trial demonstrates the effectiveness and safety of the CorPath GRX System for endovascular embolization of cerebral aneurysm procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
226. A Clinical and Imaging Fused Deep Learning Model Matches Expert Clinician Prediction of 90-Day Stroke Outcomes.
- Author
-
Yongkai Liu, Shah, Preya, Yannan Yu, Horsey, Jai, Jiahong Ouyang, Bin Jiang, Guang Yang, Heit, Jeremy J., McCullough-Hicks, Margy E., Hugdal, Stephen M., Wintermark, Max, Michel, Patrik, Liebeskind, David S., Lansberg, Maarten G., Albers, Gregory W., and Zaharchuk, Greg
- Published
- 2024
- Full Text
- View/download PDF
227. Serial ASPECTS in the DAWN Trial: Infarct Evolution and Clinical Impact
- Author
-
Liebeskind, David S., Saber, Hamidreza, Bhuva, Parita, Xiang, Bin, Yoo, Albert J., Jadhav, Ashutosh P., Haussen, Diogo C., Budzik, Ronald F., Bonafe, Alain, Yavagal, Dileep R., Hanel, Ricardo A., Ribo, Marc, Cognard, Christophe, Sila, Cathy, Hassan, Ameer E., Smith, Wade S., Saver, Jeffrey L., Nogueira, Raul G., and Jovin, Tudor G.
- Published
- 2021
- Full Text
- View/download PDF
228. First pass effect as an independent predictor of functional outcomes in medium vessel occlusions: An analysis of an international multicenter study
- Author
-
Radu, Răzvan Alexandru, primary, Costalat, Vincent, additional, Fahed, Robert, additional, Ghozy, Sherief, additional, Siegler, James E, additional, Shaikh, Hamza, additional, Khalife, Jane, additional, Abdalkader, Mohamad, additional, Klein, Piers, additional, Nguyen, Thanh N, additional, Heit, Jeremy J, additional, Sweid, Ahmad, additional, El Naamani, Kareem, additional, Regenhardt, Robert W, additional, Diestro, Jose Danilo Bengzon, additional, Cancelliere, Nicole M, additional, Amllay, Abdelaziz, additional, Meyer, Lukas, additional, Dusart, Anne, additional, Bellante, Flavio, additional, Forestier, Géraud, additional, Rouchaud, Aymeric, additional, Saleme, Suzana, additional, Mounayer, Charbel, additional, Fiehler, Jens, additional, Kühn, Anna Luisa, additional, Puri, Ajit S, additional, Dyzmann, Christian, additional, Kan, Peter T, additional, Colasurdo, Marco, additional, Marnat, Gaultier, additional, Berge, Jérôme, additional, Barreau, Xavier, additional, Sibon, Igor, additional, Nedelcu, Simona, additional, Henninger, Nils, additional, Kyheng, Maéva, additional, Marotta, Thomas R, additional, Stapleton, Christopher J, additional, Rabinov, James D, additional, Ota, Takahiro, additional, Dofuku, Shogo, additional, Yeo, Leonard LL, additional, Tan, Benjamin YQ, additional, Martinez-Gutierrez, Juan Carlos, additional, Salazar-Marioni, Sergio, additional, Sheth, Sunil, additional, Renieri, Leonardo, additional, Capirossi, Carolina, additional, Mowla, Ashkan, additional, Tjoumakaris, Stavropoula I, additional, Jabbour, Pascal, additional, Khandelwal, Priyank, additional, Biswas, Arundhati, additional, Clarençon, Frédéric, additional, Elhorany, Mahmoud, additional, Premat, Kevin, additional, Valente, Iacopo, additional, Pedicelli, Alessandro, additional, Pedro Filipe, João, additional, Varela, Ricardo, additional, Quintero-Consuegra, Miguel, additional, Gonzalez, Nestor R, additional, Möhlenbruch, Markus A, additional, Jesser, Jessica, additional, Tancredi, Illario, additional, ter Schiphorst, Adrien, additional, Yedavalli, Vivek, additional, Harker, Pablo, additional, Chervak, Lina M, additional, Aziz, Yasmin, additional, Gory, Benjamin, additional, Paul Stracke, Christian, additional, Hecker, Constantin, additional, Killer-Oberpfalzer, Monika, additional, Griessenauer, Christoph J, additional, Thomas, Ajith J, additional, Hsieh, Cheng-Yang, additional, Liebeskind, David S, additional, Alexandre, Andrea M, additional, Faizy, Tobias D, additional, Weyland, Charlotte, additional, Patel, Aman B, additional, Pereira, Vitor Mendes, additional, Lubicz, Boris, additional, Dmytriw, Adam A, additional, and Guenego, Adrien, additional
- Published
- 2023
- Full Text
- View/download PDF
229. Perfusion Collateral Index versus Hypoperfusion Intensity Ratio in Assessment of Collaterals in Patients with Acute Ischemic Stroke
- Author
-
Tsui, Brian, primary, Chen, Iris E., additional, Nour, May, additional, Kihira, Shingo, additional, Tavakkol, Elham, additional, Polson, Jennifer, additional, Zhang, Haoyue, additional, Qiao, Joe, additional, Bahr-Hosseini, Mersedeh, additional, Arnold, Corey, additional, Tateshima, Satoshi, additional, Salamon, Noriko, additional, Villablanca, J. Pablo, additional, Colby, Geoffrey P., additional, Jahan, Reza, additional, Duckwiler, Gary, additional, Saver, Jeffrey L., additional, Liebeskind, David S., additional, and Nael, Kambiz, additional
- Published
- 2023
- Full Text
- View/download PDF
230. Evaluation of effectiveness and safety of the CorPath GRX robotic system in endovascular embolization procedures of cerebral aneurysms
- Author
-
Mendes Pereira, Vitor, primary, Rice, Hal, additional, De Villiers, Laetitia, additional, Sourour, Nader, additional, Clarencon, Frédéric, additional, Spears, Julian, additional, Tomasello, Alejandro, additional, Hernandez, David, additional, Cancelliere, Nicole M, additional, Liu, Xiao Yu Eileen, additional, Nicholson, Patrick, additional, Costalat, Vincent, additional, Gascou, Gregory, additional, Mordasini, Pasquale, additional, Gralla, Jan, additional, Martínez-Galdámez, Mario, additional, Galvan Fernandez, Jorge, additional, Killer-Oberpfalzer, Monika, additional, Liebeskind, David S, additional, Turner, Raymond D, additional, Blanc, Raphael, additional, and Piotin, Michel, additional
- Published
- 2023
- Full Text
- View/download PDF
231. Delayed Diagnosis in Cerebral Venous Thrombosis: Associated Factors and Clinical Outcomes
- Author
-
Bakradze, Ekaterina, primary, Shu, Liqi, additional, Henninger, Nils, additional, Prabhakaran, Shyam, additional, Siegler, James E., additional, De Marchis, Gian Marco, additional, Giles, James A., additional, Dittrich, Tolga, additional, Heldner, Mirjam R., additional, Antonenko, Kateryna, additional, Kam, Wayneho, additional, Liebeskind, David S., additional, Simpkins, Alexis N., additional, Nguyen, Thanh N., additional, Yaghi, Shadi, additional, and Liberman, Ava L., additional
- Published
- 2023
- Full Text
- View/download PDF
232. Polygenic Risk of Epilepsy and Post-Stroke Epilepsy
- Author
-
Rivier, Cyprien A, primary, Clocchiatti-Tuozzo, Santiago, additional, Misra, Shubham, additional, Zelano, Johan, additional, Mazumder, Rajarshi, additional, Sansing, Lauren, additional, de Havenon, Adam, additional, Hirsch, Lawrence, additional, Liebeskind, David S, additional, Gilmore, Emily, additional, Sheth, Kevin N, additional, Kim, Jennifer A, additional, Worrall, Bradford B, additional, Falcone, Guido J., additional, and Mishra, Nishant, additional
- Published
- 2023
- Full Text
- View/download PDF
233. Clinical evidence in ischemic stroke: Where we have gone so far and hopes for the future
- Author
-
Li, Tianhua, primary, Song, Chengyu, additional, Liebeskind, David S., additional, Dmytriw, Adam A., additional, Xu, Ran, additional, Wang, Xue, additional, Wang, Jie, additional, Zhao, Hengxiao, additional, Cao, Wenbo, additional, Gong, Haozhi, additional, Zhang, Chao, additional, Bai, Xuesong, additional, and Jiao, Liqun, additional
- Published
- 2023
- Full Text
- View/download PDF
234. Time to Reperfusion Is Not Associated With Functional Outcomes in First‐Pass Reperfusion: Analysis of the STRATIS Registry
- Author
-
Manning, Nathan W., primary, Hassan, Ameer E., additional, Liebeskind, David S., additional, Mueller‐Kronast, Nils H., additional, Jadhav, Ashutosh P., additional, Nogueira, Raul G., additional, Yavagal, Dileep R., additional, Cheung, Andrew, additional, Wenderoth, Jason, additional, and Zaidat, Osama O., additional
- Published
- 2023
- Full Text
- View/download PDF
235. Endovascular Treatment for Acute Large Vessel Occlusion Due to Underlying Intracranial Atherosclerotic Disease
- Author
-
Huo, Xiaochuan, additional, Sun, Dapeng, additional, Chen, Wenhuo, additional, Han, Hongxing, additional, Abdalkader, Mohamad, additional, Puetz, Volker, additional, Yi, Tingyu, additional, Wang, Hao, additional, Liu, Raynald, additional, Tong, Xu, additional, Jia, Baixue, additional, Ma, Ning, additional, Gao, Feng, additional, Mo, Dapeng, additional, Yan, Bernard, additional, Mitchell, Peter J., additional, Leung, Thomas W., additional, Yavagal, Dileep R., additional, Albers, Gregory W., additional, Costalat, Vincent, additional, Fiehler, Jens, additional, Zaidat, Osama O., additional, Jovin, Tudor G., additional, Liebeskind, David S., additional, Nguyen, Thanh N., additional, and Miao, Zhongrong, additional
- Published
- 2023
- Full Text
- View/download PDF
236. High‐resolution magnetic resonance imaging of acute intracranial artery thrombus
- Author
-
Zhang, Zong‐Mu‐Yu, primary, Si, Qian‐Qian, additional, Chen, Hui‐Sheng, additional, Yang, Yi, additional, Zhang, Meng, additional, Wu, Shi‐Wen, additional, Meng, Yao, additional, Li, Ming‐Li, additional, Lin, Qian‐Qian, additional, Liebeskind, David S., additional, Huang, Yi‐Ning, additional, and Xu, Wei‐Hai, additional
- Published
- 2023
- Full Text
- View/download PDF
237. Optimizing Prediction Scores for Poor Outcome After Intra-Arterial Therapy in Anterior Circulation Acute Ischemic Stroke
- Author
-
Sarraj, Amrou, Albright, Karen, Barreto, Andrew D, Boehme, Amelia K, Sitton, Clark W, Choi, Jeanie, Lutzker, Steven L, Sun, Chung-Huan J, Bibars, Wafi, Nguyen, Claude B, Mir, Osman, Vahidy, Farhaan, Wu, Tzu-Ching, Lopez, George A, Gonzales, Nicole R, Edgell, Randall, Martin-Schild, Sheryl, Hallevi, Hen, Chen, Peng Roc, Dannenbaum, Mark, Saver, Jeffrey L, Liebeskind, David S, Nogueira, Raul G, Gupta, Rishi, Grotta, James C, and Savitz, Sean I
- Subjects
Clinical Research ,Brain Disorders ,Neurosciences ,Stroke ,4.2 Evaluation of markers and technologies ,Detection ,screening and diagnosis ,Adolescent ,Adult ,Aged ,Aged ,80 and over ,Brain Ischemia ,Female ,Fibrinolytic Agents ,Humans ,Injections ,Intra-Arterial ,Male ,Middle Aged ,Predictive Value of Tests ,Prognosis ,Radiography ,Reperfusion ,Retrospective Studies ,Severity of Illness Index ,Thrombolytic Therapy ,Tissue Plasminogen Activator ,Treatment Outcome ,acute ischemic stroke ,HIAT2 ,intra-arterial therapy ,prediction scores ,thrombolysis ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
Background and purposeIntra-arterial therapy (IAT) promotes recanalization of large artery occlusions in acute ischemic stroke. Despite high recanalization rates, poor clinical outcomes are common. We attempted to optimize a score that combines clinical and imaging variables to more accurately predict poor outcome after IAT in anterior circulation occlusions.MethodsPatients with acute ischemic stroke undergoing IAT at University of Texas (UT) Houston for large artery occlusions (middle cerebral artery or internal carotid artery) were reviewed. Independent predictors of poor outcome (modified Rankin Scale, 4-6) were studied. External validation was performed on IAT-treated patients at Emory University.ResultsA total of 163 patients were identified at UT Houston. Independent predictors of poor outcome (P≤0.2) were identified as score variables using sensitivity analysis and logistic regression. Houston Intra-Arterial Therapy 2 (HIAT2) score ranges 0 to 10: age (≤59=0, 60-79=2, ≥80 years=4), glucose (
- Published
- 2013
238. THRIVE Score Predicts Outcomes With a Third-Generation Endovascular Stroke Treatment Device in the TREVO-2 Trial
- Author
-
Flint, Alexander C, Xiang, Bin, Gupta, Rishi, Nogueira, Raul G, Lutsep, Helmi L, Jovin, Tudor G, Albers, Gregory W, Liebeskind, David S, Sanossian, Nerses, and Smith, Wade S
- Subjects
Brain Disorders ,Stroke ,Aging ,Clinical Research ,Detection ,screening and diagnosis ,4.2 Evaluation of markers and technologies ,Aged ,Aged ,80 and over ,Brain Ischemia ,Combined Modality Therapy ,Endovascular Procedures ,Female ,Fibrinolytic Agents ,Humans ,Male ,Middle Aged ,Predictive Value of Tests ,Tissue Plasminogen Activator ,Treatment Outcome ,cerebral hemorrhage ,forecasting ,outcome assessment ,stroke ,TREVO-2 Trialists ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Neurosciences ,Neurology & Neurosurgery - Abstract
Background and purposeSeveral outcome prediction scores have been tested in patients receiving acute stroke treatment with previous generations of endovascular stroke treatment devices. The TREVO-2 trial was a randomized controlled trial comparing a novel endovascular stroke treatment device (the Trevo device) to a previous-generation endovascular stroke treatment device (the Merci device).MethodsWe used data from the TREVO-2 trial to validate the Totaled Health Risks in Vascular Events (THRIVE) score in patients receiving treatment with a third-generation endovascular stroke treatment device and to compare THRIVE to other predictive scores. We used logistic regression to model outcomes and compared score performance with receiver operating characteristic curve analysis.ResultsIn the TREVO-2 trial, the THRIVE score strongly predicts clinical outcome and mortality. The relationship between THRIVE score and outcome is not influenced by either success of recanalization or the type of device used (Trevo versus Merci). The superiority of the Trevo device to the Merci device is evident particularly among patients with a low-to-moderate THRIVE score (0-5; 53.8% good outcome with Trevo versus 27.5% good outcome with Merci). In receiver operating characteristic curve analysis, the THRIVE score was comparable or superior to several other outcome prediction scores (HIAT, HIAT-2, SPAN-100, and iScore).ConclusionsThe THRIVE score strongly predicts clinical outcome and mortality in the TREVO-2 trial. Taken together with THRIVE validation data from patients receiving intravenous tissue-type plasminogen activator or no acute treatment, the THRIVE score has broad predictive power in patients with acute ischemic stroke, which is likely because THRIVE reflects a set of strong nonmodifiable predictors of stroke outcome. A free Web calculator for the THRIVE score is available at http://www.thrivescore.org.
- Published
- 2013
239. Stroke Treatment Academic Industry Roundtable
- Author
-
Saver, Jeffrey L, Jovin, Tudor G, Smith, Wade S, Albers, Gregory W, Baron, Jean-Claude, Boltze, Johannes, Broderick, Joseph P, Davis, Lisa A, Demchuk, Andrew M, DeSena, Salvatore, Fiehler, Jens, Gorelick, Philip B, Hacke, Werner, Holt, Bill, Jahan, Reza, Jing, Hui, Khatri, Pooja, Kidwell, Chelsea S, Lees, Kennedy R, Lev, Michael H, Liebeskind, David S, Luby, Marie, Lyden, Patrick, Megerian, J Thomas, Mocco, J, Muir, Keith W, Rowley, Howard A, Ruedy, Richard M, Savitz, Sean I, Sipelis, Vitas J, Shimp, Samuel K, Wechsler, Lawrence R, Wintermark, Max, Wu, Ona, Yavagal, Dileep R, and Yoo, Albert J
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Clinical Trials and Supportive Activities ,Stroke ,Clinical Research ,Biomedical Imaging ,Brain Ischemia ,Clinical Trials as Topic ,Fibrinolytic Agents ,Humans ,Research Design ,Thrombectomy ,Thrombolytic Therapy ,endovascular recanalization ,ischemic ,reperfusion ,stroke ,STAIR VIII Consortium ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Neurosciences ,Neurology & Neurosurgery ,Clinical sciences ,Allied health and rehabilitation science - Abstract
Background and purposeThe goal of the Stroke Treatment Academic Industry Roundtable (STAIR) meetings is to advance the development of stroke therapies. At STAIR VIII, consensus recommendations were developed for clinical trial strategies to demonstrate the benefit of endovascular reperfusion therapies for acute ischemic stroke.Summary of reviewProspects for success with forthcoming endovascular trials are robust, because new neurothrombectomy devices have superior reperfusion efficacy compared with earlier-generation interventions. Specific recommendations are provided for trial designs in 3 populations: (1) patients undergoing intravenous fibrinolysis, (2) early patients ineligible for or having failed intravenous fibrinolysis, and (3) wake-up and other late-presenting patients. Among intravenous fibrinolysis-eligible patients, key principles are that CT or MRI confirmation of target arterial occlusions should precede randomization; endovascular intervention should be pursued with the greatest rapidity possible; and combined intravenous and neurothrombectomy therapy is more promising than neurothrombectomy alone. Among patients ineligible for or having failed intravenous fibrinolysis, scientific equipoise was affirmed and the need to randomize all eligible patients emphasized. Vessel imaging to confirm occlusion is mandatory, and infarct core and penumbral imaging is desirable in later time windows. Additional STAIR VIII recommendations include approaches to test multiple devices in a single trial, utility weighting of disability end points, and adaptive designs to delineate time and tissue injury thresholds at which benefits from intervention no longer accrue.ConclusionsEndovascular research priorities in acute ischemic stroke are to perform trials testing new, highly effective neuro thrombectomy devices rapidly deployed in patients confirmed to have target vessel occlusions.
- Published
- 2013
240. Imaging Recommendations for Acute Stroke and Transient Ischemic Attack Patients A Joint Statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery
- Author
-
Wintermark, Max, Sanelli, Pina C, Albers, Gregory W, Bello, Jacqueline A, Derdeyn, Colin P, Hetts, Steven W, Johnson, Michele H, Kidwell, Chelsea S, Lev, Michael H, Liebeskind, David S, Rowley, Howard A, Schaefer, Pamela W, Sunshine, Jeffrey L, Zaharchuk, Greg, and Meltzer, Carolyn C
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Biomedical Imaging ,Brain Disorders ,Stroke ,Decision Trees ,Diagnostic Imaging ,Humans ,Ischemic Attack ,Transient ,Neurology ,Radiology ,United States ,thrombolysis ,computed tomography ,magnetic resonance imaging ,catheter angiography ,American Society of Neuroradiology ,American College of Radiology ,Society of NeuroInterventional Surgery ,Public Health and Health Services ,Nuclear Medicine & Medical Imaging ,Clinical sciences - Abstract
In the article entitled "Imaging Recommendations for Acute Stroke and Transient Ischemic Attack Patients: A Joint Statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery", we are proposing a simple, pragmatic approach that will allow the reader to develop an optimal imaging algorithm for stroke patients at their institution.
- Published
- 2013
241. Quantitative Analysis of Hypoperfusion in Acute Stroke
- Author
-
Nael, Kambiz, Meshksar, Arash, Liebeskind, David S, Coull, Bruce M, Krupinski, Elizabeth A, and Villablanca, J Pablo
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Neurosciences ,Adult ,Aged ,Aged ,80 and over ,Arteries ,Brain Infarction ,Cerebrovascular Circulation ,Contrast Media ,Diffusion ,Female ,Humans ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Perfusion ,Perfusion Imaging ,Retrospective Studies ,Spin Labels ,Stroke ,ASL ,cerebral revascularization ,perfusion-weighted MRI ,reperfusion ,stroke ,Cardiorespiratory Medicine and Haematology ,Neurology & Neurosurgery ,Clinical sciences ,Allied health and rehabilitation science - Abstract
Background and purposeThis study compares the concordance between arterial spin labeling (ASL) and dynamic susceptibility contrast (DSC) for the identification of regional hypoperfusion and diffusion-perfusion mismatch tissue classification using a quantitative method.MethodsThe inclusion criteria for this retrospective study were as follows: patients with acute ischemic syndrome with symptom onset 6 sec as the reference. In a subset of patients who were successfully recanalized, the identical analysis was performed and the infarction and hypoperfused lesion volumes were used for paired pre- and posttreatment comparisons.ResultsForty-one patients met our inclusion criteria. Twenty patients underwent successful endovascular revascularization (TICI>2a), resulting in a total of 61 ASL-DSC data pairs for comparison. The hypoperfusion volume on ASL-cerebral blood flow best approximated the DSC-time to peak volume (r=0.83) in pretreatment group and time to maximum (r=0.46) after recanalization. Both ASL-cerebral blood flow and DSC-TTP overestimated the hypoperfusion volume compared with time to maximum volume in pretreatment (F=27.41, P
- Published
- 2013
242. Interobserver Reproducibility of Signal Intensity Ratio on Magnetic Resonance Angiography for Hemodynamic Impact of Intracranial Atherosclerosis
- Author
-
Leng, Xinyi, Ip, Hing Lung, Soo, Yannie, Leung, Thomas, Liu, Liping, Feldmann, Edward, Wong, Ka Sing, and Liebeskind, David S
- Subjects
Clinical Research ,Atherosclerosis ,Basilar Artery ,Carotid Artery ,Internal ,Cerebrovascular Circulation ,China ,Constriction ,Pathologic ,Hemodynamics ,Humans ,Intracranial Arteriosclerosis ,Magnetic Resonance Angiography ,Middle Cerebral Artery ,Observer Variation ,Predictive Value of Tests ,Reproducibility of Results ,Retrospective Studies ,Interobserver reproducibility ,intracranial atherosclerosis ,magnetic resonance angiography ,signal intensity ,hemodynamics ,Clinical Sciences ,Neurosciences ,Neurology & Neurosurgery - Abstract
BackgroundChanges of signal intensities (SIs) across intracranial atherosclerosis (ICAS) on magnetic resonance angiography (MRA) may reflect hemodynamic impact of the lesion. We evaluated the interobserver reproducibility of an index termed signal intensity ratio (SIR), developed in a previous study to represent the changes of SIs across ICAS on MRA.MethodsSymptomatic ICAS on MRA were retrospectively recruited. Two observers respectively evaluated the images and calculated the SIR as follows, blinded to each other's readings: SIR=(mean poststenotic SI-mean background SI)/(mean prestenotic SI-mean background SI). Statistical analyses were performed to evaluate the interobserver reproducibility of this index.ResultsA total of 102 symptomatic ICASs were enrolled, with 36 (35.3%) lesions of 50%-69% MRA stenoses and others being 70%-99% stenoses or flow void on MRA. Overall, mean SIRs were not significantly different between the 2 observers (.92±.17 versus .93±.17; mean difference -.006±.09; P=.496 for paired t test). Pearson correlation coefficients were >.80 for all analyses, indicating strong linear correlations between SIRs by the 2 observers. Bland-Altman analysis for SIRs of all cases showed no systematic bias between the 2 observers. For different cut-points ranging from .75 to 1.00, the kappa statistics were mostly greater than .6 and interobserver agreements were all greater than 80%, implying substantial agreement between observers.ConclusionsSIR was demonstrated to be highly reproducible between observers in the present study. Future studies are warranted to further explore the role of this index in comprehensive evaluation and risk stratification of symptomatic ICAS.
- Published
- 2013
243. Arterial Anatomy and Collaterals
- Author
-
Atchaneeyasakul, Kunakorn, primary and Liebeskind, David S., additional
- Published
- 2020
- Full Text
- View/download PDF
244. Recent Success with Endovascular Stroke Therapy
- Author
-
Malhotra, Konark, Liebeskind, David S., Chen, Zhu, Series editor, Shen, Xiaoming, Series editor, Chen, Saijuan, Series editor, Dai, Kerong, Series editor, Lapchak, Paul A., editor, and Yang, Guo-Yuan, editor
- Published
- 2017
- Full Text
- View/download PDF
245. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
- Author
-
Berkhemer, Olvert A, Fransen, Puck SS, Beumer, Debbie, van den Berg, Lucie A, Lingsma, Hester F, Yoo, Albert J, Schonewille, Wouter J, Vos, Jan Albert, Nederkoorn, Paul J, Wermer, Marieke JH, van Walderveen, Marianne AA, Staals, Julie, Hofmeijer, Jeannette, van Oostayen, Jacques A., Lycklama à Nijeholt, Geert J., Boiten, Jelis, Brouwer, Patrick A., Emmer, Bart J., de Bruijn, Sebastiaan F., van Dijk, Lukas C., Kappelle, Jaap, Lo, Rob H, van Dijk, Ewoud J., de Vries, Joost, de Kort, Paul L.M., van Rooij, Willem Jan J., van den Berg, Jan S.P., van Hasselt, Boudewijn A.A.M., Aerden, Leo A.M., Dallinga, René J., Visser, Marieke C., Bot, Joseph C.J., Vroomen, Patrick C., Eshghi, Omid, Schreuder, Tobien H.C.M.L., Heijboer, Roel J.J., Keizer, Koos, Tielbeek, Alexander V., den Hertog, Heleen M., Gerrits, Dick G., van den Berg-Vos, Renske M., Karas, Giorgos B., Steyerberg, Ewout W., Flach, Zwenneke, Marquering, Henk A., Sprengers, Marieke E.S., Jenniskens, Sjoerd F.M., Beenen, Ludo F.M., van den Berg, René, Koudstaal, Peter J., van Zwam, Wim H., Roos, Yvo B.W.E.M., van der Lugt, Aad, van Oostenbrugge, Robert J., Majoie, Charles B.L.M., Dippel, Diederik W.J., Brown, Martin M., Liebig, Thomas, Stijnen, Theo, Andersson, Tommy, Mattle, Heinrich, Wahlgren, Nils, van der Heijden, Esther, Ghannouti, Naziha, Fleitour, Nadine, Hooijenga, Imke, Puppels, Corina, Pellikaan, Wilma, Geerling, Annet, Lindl-Velema, Annemieke, van Vemde, Gina, de Ridder, Ans, Greebe, Paut, de Bont-Stikkelbroeck, José, de Meris, Joke, Janssen, Kirsten, Struijk, Willy, Licher, Silvan, Boodt, Nikki, Ros, Adriaan, Venema, Esmee, Slokkers, Ilse, Ganpat, Raymie-Jayce, Mulder, Maxim, Saiedie, Nawid, Heshmatollah, Alis, Schipperen, Stefanie, Vinken, Stefan, van Boxtel, Tiemen, Koets, Jeroen, Boers, Merel, Santos, Emilie, Borst, Jordi, Jansen, Ivo, Kappelhof, Manon, Lucas, Marit, Geuskens, Ralph, Barros, Renan Sales, Dobbe, Roeland, Csizmadia, Marloes, Hill, MD, Goyal, M, Demchuk, AM, Menon, BK, Eesa, M, Ryckborst, KJ, Wright, MR, Kamal, NR, Andersen, L, Randhawa, PA, Stewart, T, Patil, S, Minhas, P, Almekhlafi, M, Mishra, S, Clement, F, Sajobi, T, Shuaib, A, Montanera, WJ, Roy, D, Silver, FL, Jovin, TG, Frei, DF, Sapkota, B, Rempel, JL, Thornton, J, Williams, D, Tampieri, D, Poppe, AY, Dowlatshahi, D, Wong, JH, Mitha, AP, Subramaniam, S, Hull, G, Lowerison, MW, Salluzzi, M, Maxwell, M, Lacusta, S, Drupals, E, Armitage, K, Barber, PA, Smith, EE, Morrish, WF, Coutts, SB, Derdeyn, C, Demaerschalk, B, Yavagal, D, Martin, R, Brant, R, Yu, Y, Willinsky, RA, Weill, A, Kenney, C, Aram, H, Stys, PK, Watson, TW, Klein, G, Pearson, D, Couillard, P, Trivedi, A, Singh, D, Klourfeld, E, Imoukhuede, O, Nikneshan, D, Blayney, S, Reddy, R, Choi, P, Horton, M, Musuka, T, Dubuc, V, Field, TS, Desai, J, Adatia, S, Alseraya, A, Nambiar, V, van Dijk, R, Newcommon, NJ, Schwindt, B, Butcher, KS, Jeerakathil, T, Buck, B, Khan, K, Naik, SS, Emery, DJ, Owen, RJ, Kotylak, TB, Ashforth, RA, Yeo, TA, McNally, D, Siddiqui, M, Saqqur, M, Hussain, D, Kalashyan, H, Manosalva, A, Kate, M, Gioia, L, Hasan, S, Mohammad, A, Muratoglu, M, Cullen, A, Brennan, P, O'Hare, A, Looby, S, Hyland, D, Duff, S, McCusker, M, Hallinan, B, Lee, S, McCormack, J, Moore, A, O'Connor, M, Donegan, C, Brewer, L, Martin, A, Murphy, S, O'Rourke, K, Smyth, S, Kelly, P, Lynch, T, Daly, T, O'Brien, P, O'Driscoll, A, Martin, M, Collins, R, Coughlan, T, McCabe, D, O'Neill, D, Mulroy, M, Lynch, O, Walsh, T, O'Donnell, M, Galvin, T, Harbison, J, McElwaine, P, Mulpeter, K, McLoughlin, C, Reardon, M, Harkin, E, Dolan, E, Watts, M, Cunningham, N, Fallon, C, Gallagher, S, Cotter, P, Crowe, M, Doyle, R, Noone, I, Lapierre, M, Coté, VA, Lanthier, S, Odier, C, Durocher, A, Raymond, J, Daneault, N, Deschaintre, Y, Jankowitz, B, Baxendell, L, Massaro, L, Jackson-Graves, C, Decesare, S, Porter, P, Armbruster, K, Adams, A, Billigan, J, Oakley, J, Ducruet, A, Jadhav, A, Giurgiutiu, D-V, Aghaebrahim, A, Reddy, V, Hammer, M, Starr, M, Totoraitis, V, Wechsler, L, Streib, S, Rangaraju, S, Campbell, D, Rocha, M, Gulati, D, Krings, T, Kalman, L, Cayley, A, Williams, J, Wiegner, R, Casaubon, LK, Jaigobin, C, del Campo, JM, Elamin, E, Schaafsma, JD, Agid, R, Farb, R, ter Brugge, K, Sapkoda, BL, Baxter, BW, Barton, K, Knox, A, Porter, A, Sirelkhatim, A, Devlin, T, Dellinger, C, Pitiyanuvath, N, Patterson, J, Nichols, J, Quarfordt, S, Calvert, J, Hawk, H, Fanale, C, Bitner, A, Novak, A, Huddle, D, Bellon, R, Loy, D, Wagner, J, Chang, I, Lampe, E, Spencer, B, Pratt, R, Bartt, R, Shine, S, Dooley, G, Nguyen, T, Whaley, M, McCarthy, K, Teitelbaum, J, Poon, W, Campbell, N, Cortes, M, Lum, C, Shamloul, R, Robert, S, Stotts, G, Shamy, M, Steffenhagen, N, Blacquiere, D, Hogan, M, AlHazzaa, M, Basir, G, Lesiuk, H, Iancu, D, Santos, M, Choe, H, Weisman, DC, Jonczak, K, Blue-Schaller, A, Shah, Q, MacKenzie, L, Klein, B, Kulandaivel, K, Kozak, O, Gzesh, DJ, Harris, LJ, Khoury, JS, Mandzia, J, Pelz, D, Crann, S, Fleming, L, Hesser, K, Beauchamp, B, Amato-Marzialli, B, Boulton, M, Lopez-Ojeda, P, Sharma, M, Lownie, S, Chan, R, Swartz, R, Howard, P, Golob, D, Gladstone, D, Boyle, K, Boulos, M, Hopyan, J, Yang, V, Da Costa, L, Holmstedt, CA, Turk, AS, Navarro, R, Jauch, E, Ozark, S, Turner, R, Phillips, S, Shankar, J, Jarrett, J, Gubitz, G, Maloney, W, Vandorpe, R, Schmidt, M, Heidenreich, J, Hunter, G, Kelly, M, Whelan, R, Peeling, L, Burns, PA, Hunter, A, Wiggam, I, Kerr, E, Watt, M, Fulton, A, Gordon, P, Rennie, I, Flynn, P, Smyth, G, O'Leary, S, Gentile, N, Linares, G, McNelis, P, Erkmen, K, Katz, P, Azizi, A, Weaver, M, Jungreis, C, Faro, S, Shah, P, Reimer, H, Kalugdan, V, Saposnik, G, Bharatha, A, Li, Y, Kostyrko, P, Marotta, T, Montanera, W, Sarma, D, Selchen, D, Spears, J, Heo, JH, Jeong, K, Kim, DJ, Kim, BM, Kim, YD, Song, D, Lee, K-J, Yoo, J, Bang, OY, Rho, S, Lee, J, Jeon, P, Kim, KH, Cha, J, Kim, SJ, Ryoo, S, Lee, MJ, Sohn, S-I, Kim, C-H, Ryu, H-G, Hong, J-H, Chang, H-W, Lee, C-Y, Rha, J, Davis, Stephen M, Donnan, Geoffrey A, Campbell, Bruce CV, Mitchell, Peter J, Churilov, Leonid, Yan, Bernard, Dowling, Richard, Yassi, Nawaf, Oxley, Thomas J, Wu, Teddy Y, Silver, Gabriel, McDonald, Amy, McCoy, Rachael, Kleinig, Timothy J, Scroop, Rebecca, Dewey, Helen M, Simpson, Marion, Brooks, Mark, Coulton, Bronwyn, Krause, Martin, Harrington, Timothy J, Steinfort, Brendan, Faulder, Kenneth, Priglinger, Miriam, Day, Susan, Phan, Thanh, Chong, Winston, Holt, Michael, Chandra, Ronil V, Ma, Henry, Young, Dennis, Wong, Kitty, Wijeratne, Tissa, Tu, Hans, Mackay, Elizabeth, Celestino, Sherisse, Bladin, Christopher F, Loh, Poh Sien, Gilligan, Amanda, Ross, Zofia, Coote, Skye, Frost, Tanya, Parsons, Mark W, Miteff, Ferdinand, Levi, Christopher R, Ang, Timothy, Spratt, Neil, Kaauwai, Lara, Badve, Monica, Rice, Henry, de Villiers, Laetitia, Barber, P. Alan, McGuinness, Ben, Hope, Ayton, Moriarty, Maurice, Bennett, Patricia, Wong, Andrew, Coulthard, Alan, Lee, Andrew, Jannes, Jim, Field, Deborah, Sharma, Gagan, Salinas, Simon, Cowley, Elise, Snow, Barry, Kolbe, John, Stark, Richard, King, John, Macdonnell, Richard, Attia, John, D'Este, Cate, Saver, Jeffrey L, Goyal, Mayank, Diener, Hans-Christoph, Levy, Elad I., Bonafé, Alain, Mendes Pereira, Vitor, Jahan, Reza, Albers, Gregory W., Cognard, Christophe, Cohen, David J., Hacke, Werner, Jansen, Olav, Jovin, Tudor G., Mattle, Heinrich P., Nogueira, Raul G., Siddiqui, Adnan H., Yavagal, Dileep R., von Kummer, Rüdiger, Smith, Wade, Turjman, Francis, Hamilton, Scott, Chiacchierini, Richard, Amar, Arun, Sanossian, Nerses, Loh, Yince, Baxter, B, Reddy, VK, Horev, A, Star, M, Siddiqui, A, Hopkins, LN, Snyder, K, Sawyer, R, Hall, S, Costalat, V, Riquelme, C, Machi, P, Omer, E, Arquizan, C, Mourand, I, Charif, M, Ayrignac, X, Menjot de Champfleur, N, Leboucq, N, Gascou, G, Moynier, M, du Mesnil de Rochemont, R, Singer, O, Berkefeld, J, Foerch, C, Lorenz, M, Pfeilschifer, W, Hattingen, E, Wagner, M, You, SJ, Lescher, S, Braun, H, Dehkharghani, S, Belagaje, SR, Anderson, A, Lima, A, Obideen, M, Haussen, D, Dharia, R, Frankel, M, Patel, V, Owada, K, Saad, A, Amerson, L, Horn, C, Doppelheuer, S, Schindler, K, Lopes, DK, Chen, M, Moftakhar, R, Anton, C, Smreczak, M, Carpenter, JS, Boo, S, Rai, A, Roberts, T, Tarabishy, A, Gutmann, L, Brooks, C, Brick, J, Domico, J, Reimann, G, Hinrichs, K, Becker, M, Heiss, E, Selle, C, Witteler, A, Al-Boutros, S, Danch, M-J, Ranft, A, Rohde, S, Burg, K, Weimar, C, Zegarac, V, Hartmann, C, Schlamann, M, Göricke, S, Ringlestein, A, Wanke, I, Mönninghoff, C, Dietzold, M, Budzik, R, Davis, T, Eubank, G, Hicks, WJ, Pema, P, Vora, N, Mejilla, J, Taylor, M, Clark, W, Rontal, A, Fields, J, Peterson, B, Nesbit, G, Lutsep, H, Bozorgchami, H, Priest, R, Ologuntoye, O, Barnwell, S, Dogan, A, Herrick, K, Takahasi, C, Beadell, N, Brown, B, Jamieson, S, Hussain, MS, Russman, A, Hui, F, Wisco, D, Uchino, K, Khawaja, Z, Katzan, I, Toth, G, Cheng-Ching, E, Bain, M, Man, S, Farrag, A, George, P, John, S, Shankar, L, Drofa, A, Dahlgren, R, Bauer, A, Itreat, A, Taqui, A, Cerejo, R, Richmond, A, Ringleb, P, Bendszus, M, Möhlenbruch, M, Reiff, T, Amiri, H, Purrucker, J, Herweh, C, Pham, M, Menn, O, Ludwig, I, Acosta, I, Villar, C, Morgan, W, Sombutmai, C, Hellinger, F, Allen, E, Bellew, M, Gandhi, R, Bonwit, E, Aly, J, Ecker, RD, Seder, D, Morris, J, Skaletsky, M, Belden, J, Baker, C, Connolly, LS, Papanagiotou, P, Roth, C, Kastrup, A, Politi, M, Brunner, F, Alexandrou, M, Merdivan, H, Ramsey, C, Given II, C, Renfrow, S, Deshmukh, V, Sasadeusz, K, Vincent, F, Thiesing, JT, Putnam, J, Bhatt, A, Kansara, A, Caceves, D, Lowenkopf, T, Yanase, L, Zurasky, J, Dancer, S, Freeman, B, Scheibe-Mirek, T, Robison, J, Roll, J, Clark, D, Rodriguez, M, Fitzsimmons, B-FM, Zaidat, O, Lynch, JR, Lazzaro, M, Larson, T, Padmore, L, Das, E, Farrow-Schmidt, A, Hassan, A, Tekle, W, Cate, C, Jansen, O, Cnyrim, C, Wodarg, F, Wiese, C, Binder, A, Riedel, C, Rohr, A, Lang, N, Laufs, H, Krieter, S, Remonda, L, Diepers, M, Añon, J, Nedeltchev, K, Kahles, T, Biethahn, S, Lindner, M, Chang, V, Gächter, C, Esperon, C, Guglielmetti, M, Arenillas Lara, JF, Martínez Galdámez, M, Calleja Sanz, AI, Cortijo Garcia, E, Garcia Bermejo, P, Perez, S, Mulero Carrillo, P, Crespo Vallejo, E, Ruiz Piñero, M, Lopez Mesonero, L, Reyes Muñoz, FJ, Brekenfeld, C, Buhk, J-H, Krützelmann, A, Thomalla, G, Cheng, B, Beck, C, Hoppe, J, Goebell, E, Holst, B, Grzyska, U, Wortmann, G, Starkman, S, Duckwiler, G, Jahan, R, Rao, N, Sheth, S, Ng, K, Noorian, A, Szeder, V, Nour, M, McManus, M, Huang, J, Tarpley, J, Tateshima, S, Gonzalez, N, Ali, L, Liebeskind, D, Hinman, J, Calderon-Arnulphi, M, Liang, C, Guzy, J, Koch, S, DeSousa, K, Gordon-Perue, G, Elhammady, M, Peterson, E, Pandey, V, Dharmadhikari, S, Khandelwal, P, Malik, A, Pafford, R, Gonzalez, P, Ramdas, K, Andersen, G, Damgaard, D, Von Weitzel-Mudersbach, P, Simonsen, C, Ruiz de Morales Ayudarte, N, Poulsen, M, Sørensen, L, Karabegovich, S, Hjørringgaard, M, Hjort, N, Harbo, T, Sørensen, K, Deshaies, E, Padalino, D, Swarnkar, A, Latorre, JG, Elnour, E, El-Zammar, Z, Villwock, M, Farid, H, Balgude, A, Cross, L, Hansen, K, Holtmannspötter, M, Kondziella, D, Hoejgaard, J, Taudorf, S, Soendergaard, H, Wagner, A, Cronquist, M, Stavngaard, T, Cortsen, M, Krarup, LH, Hyldal, T, Haring, H-P, Guggenberger, S, Hamberger, M, Trenkler, J, Sonnberger, M, Nussbaumer, K, Dominger, C, Bach, E, Jagadeesan, BD, Taylor, R, Kim, J, Shea, K, Tummala, R, Zacharatos, H, Sandhu, D, Ezzeddine, M, Grande, A, Hildebrandt, D, Miller, K, Scherber, J, Hendrickson, A, Jumaa, M, Zaidi, S, Hendrickson, T, Snyder, V, Killer-Oberpfalzer, M, Mutzenbach, J, Weymayr, F, Broussalis, E, Stadler, K, Jedlitschka, A, Malek, A, Mueller-Kronast, N, Beck, P, Martin, C, Summers, D, Day, J, Bettinger, I, Holloway, W, Olds, K, Arkin, S, Akhtar, N, Boutwell, C, Crandall, S, Schwartzman, M, Weinstein, C, Brion, B, Prothmann, S, Kleine, J, Kreiser, K, Boeckh-Behrens, T, Poppert, H, Wunderlich, S, Koch, ML, Biberacher, V, Huberle, A, Gora-Stahlberg, G, Knier, B, Meindl, T, Utpadel-Fischler, D, Zech, M, Kowarik, M, Seifert, C, Schwaiger, B, Puri, A, Hou, S, Wakhloo, A, Moonis, M, Henniger, N, Goddeau, R, Massari, F, Minaeian, A, Lozano, JD, Ramzan, M, Stout, C, Patel, A, Tunguturi, A, Onteddu, S, Carandang, R, Howk, M, Ribó, M, Sanjuan, E, Rubiera, M, Pagola, J, Flores, A, Muchada, M, Meler, P, Huerga, E, Gelabert, S, Coscojuela, P, Tomasello, A, Rodriguez, D, Santamarina, E, Maisterra, O, Boned, S, Seró, L, Rovira, A, Molina, CA, Millán, M, Muñoz, L, Pérez de la Ossa, N, Gomis, M, Dorado, L, López-Cancio, E, Palomeras, E, Munuera, J, García Bermejo, P, Remollo, S, Castaño, C, García-Sort, R, Cuadras, P, Puyalto, P, Hernández-Pérez, M, Jiménez, M, Martínez-Piñeiro, A, Lucente, G, Dávalos, A, Chamorro, A, Urra, X, Obach, V, Cervera, A, Amaro, S, Llull, L, Codas, J, Balasa, M, Navarro, J, Ariño, H, Aceituno, A, Rudilosso, S, Renu, A, Macho, JM, San Roman, L, Blasco, J, López, A, Macías, N, Cardona, P, Quesada, H, Rubio, F, Cano, L, Lara, B, de Miquel, MA, Aja, L, Serena, J, Cobo, E, Albers, Gregory W, Lees, Kennedy R, Arenillas, J, Roberts, R, Al-Ajlan, F, Zimmel, L, Patel, S, Martí-Fàbregas, J, Salvat-Plana, M, Bracard, S, Ducrocq, Xavier, Anxionnat, René, Baillot, Pierre-Alexandre, Barbier, Charlotte, Derelle, Anne-Laure, Lacour, Jean-Christophe, Richard, Sébastien, Samson, Yves, Sourour, Nader, Baronnet-Chauvet, Flore, Clarencon, Frédéric, Crozier, Sophie, Deltour, Sandrine, Di Maria, Federico, Le Bouc, Raphael, Leger, Anne, Mutlu, Gurkan, Rosso, Charlotte, Szatmary, Zoltan, Yger, Marion, Zavanone, Chiara, Bakchine, Serge, Pierot, Laurent, Caucheteux, Nathalie, Estrade, Laurent, Kadziolka, Krzysztof, Leautaud, Alexandre, Renkes, Céline, Serre, Isabelle, Desal, Hubert, Guillon, Benoît, Boutoleau-Bretonniere, Claire, Daumas-Duport, Benjamin, De Gaalon, Solène, Derkinderen, Pascal, Evain, Sarah, Herisson, Fanny, Laplaud, David-Axel, Lebouvier, Thibaud, Lintia-Gaultier, Alina, Pouclet-Courtemanche, Hélène, Rouaud, Tiphaine, Rouaud Jaffrenou, Violaine, Schunck, Aurélia, Sevin-Allouet, Mathieu, Toulgoat, Frederique, Wiertlewski, Sandrine, Gauvrit, Jean-Yves, Ronziere, Thomas, Cahagne, Vincent, Ferre, Jean-Christophe, Pinel, Jean-François, Raoult, Hélène, Mas, Jean-Louis, Meder, Jean-François, Al Najjar-Carpentier, Amen-Adam, Birchenall, Julia, Bodiguel, Eric, Calvet, David, Domigo, Valérie, Godon-Hardy, Sylvie, Guiraud, Vincent, Lamy, Catherine, Majhadi, Loubna, Morin, Ludovic, Naggara, Olivier, Trystram, Denis, Turc, Guillaume, Berge, Jérôme, Sibon, Igor, Menegon, Patrice, Barreau, Xavier, Rouanet, François, Debruxelles, Sabrina, Kazadi, Annabelle, Renou, Pauline, Fleury, Olivier, Pasco-Papon, Anne, Dubas, Frédéric, Caroff, Jildaz, Godard Ducceschi, Sophie, Hamon, Marie-Aurélie, Lecluse, Alderic, Marc, Guillaume, Giroud, Maurice, Ricolfi, Frédéric, Bejot, Yannick, Chavent, Adrien, Gentil, Arnaud, Kazemi, Apolline, Osseby, Guy-Victor, Voguet, Charlotte, Mahagne, Marie-Hélène, Sedat, Jacques, Chau, Yves, Suissa, Laurent, Lachaud, Sylvain, Houdart, Emmanuel, Stapf, Christian, Buffon Porcher, Frédérique, Chabriat, Hugues, Guedin, Pierre, Herve, Dominique, Jouvent, Eric, Mawet, Jérôme, Saint-Maurice, Jean-Pierre, Schneble, Hans-Martin, Nighoghossian, Norbert, Berhoune, Nadia-Nawel, Bouhour, Françoise, Cho, Tae-Hee, Derex, Laurent, Felix, Sandra, Gervais-Bernard, Hélène, Gory, Benjamin, Manera, Luis, Mechtouff, Laura, Ritzenthaler, Thomas, Riva, Roberto, Salaris Silvio, Fabrizio, Tilikete, Caroline, Blanc, Raphael, Obadia, Michaël, Bartolini, Mario Bruno, Gueguen, Antoine, Piotin, Michel, Pistocchi, Silvia, Redjem, Hocine, Drouineau, Jacques, Neau, Jean-Philippe, Godeneche, Gaelle, Lamy, Matthias, Marsac, Emilia, Velasco, Stephane, Clavelou, Pierre, Chabert, Emmanuel, Bourgois, Nathalie, Cornut-Chauvinc, Catherine, Ferrier, Anna, Gabrillargues, Jean, Jean, Betty, Marques, Anna-Raquel, Vitello, Nicolas, Detante, Olivier, Barbieux, Marianne, Boubagra, Kamel, Favre Wiki, Isabelle, Garambois, Katia, Tahon, Florence, Ashok, Vasdev, Coskun, Oguzhan, Rodesch, Georges, Lapergue, Bertrand, Bourdain, Frédéric, Evrard, Serge, Graveleau, Philippe, Decroix, Jean Pierre, Wang, Adrien, Sellal, François, Ahle, Guido, Carelli, Gabriela, Dugay, Marie-Hélène, Gaultier, Claude, Lebedinsky, Ariel Pablo, Lita, Lavinia, Musacchio, Raul Mariano, Renglewicz-Destuynder, Catherine, Tournade, Alain, Vuillemet, Françis, Montoro, Francisco Macian, Mounayer, Charbel, Faugeras, Frederic, Gimenez, Laetitia, Labach, Catherine, Lautrette, Géraldine, Denier, Christian, Saliou, Guillaume, Chassin, Olivier, Dussaule, Claire, Melki, Elsa, Ozanne, Augustin, Puccinelli, Francesco, Sachet, Marina, Sarov, Mariana, Bonneville, Jean-François, Moulin, Thierry, Biondi, Alessandra, De Bustos Medeiros, Elisabeth, Vuillier, Fabrice, Courtheoux, Patrick, Viader, Fausto, Apoil-Brissard, Marion, Bataille, Mathieu, Bonnet, Anne-Laure, Cogez, Julien, Touze, Emmanuel, Leclerc, Xavier, Leys, Didier, Aggour, Mohamed, Aguettaz, Pierre, Bodenant, Marie, Cordonnier, Charlotte, Deplanque, Dominique, Girot, Marie, Henon, Hilde, Kalsoum, Erwah, Lucas, Christian, Pruvo, Jean-Pierre, Zuniga, Paolo, Arquizan, Caroline, Costalat, Vincent, Machi, Paolo, Mourand, Isabelle, Riquelme, Carlos, Bounolleau, Pierre, Arteaga, Charles, Faivre, Anthony, Bintner, Marc, Tournebize, Patrice, Charlin, Cyril, Darcel, Françoise, Gauthier-Lasalarie, Pascale, Jeremenko, Marcia, Mouton, Servane, Zerlauth, Jean-Baptiste, Lamy, Chantal, Hervé, Deramond, Hassan, Hosseini, Gaston, André, Barral, Francis-Guy, Garnier, Pierre, Beaujeux, Rémy, Wolff, Valérie, Herbreteau, Denis, Debiais, Séverine, Murray, Alicia, Ford, Gary, Muir, Keith W, White, Philip, Brown, Martin M, Clifton, Andy, Freeman, Janet, Ford, Ian, Markus, Hugh, Wardlaw, Joanna, Molyneux, Andy, Robinson, Thompson, Lewis, Steff, Norrie, John, Robertson, Fergus, Perry, Richard, Dixit, Anand, Cloud, Geoffrey, Clifton, Andrew, Madigan, Jeremy, Roffe, Christine, Nayak, Sanjeev, Lobotesis, Kyriakos, Smith, Craig, Herwadkar, Amit, Kandasamy, Naga, Goddard, Tony, Bamford, John, Subramanian, Ganesh, Lenthall, Rob, Littleton, Edward, Lamin, Sal, Storey, Kelley, Ghatala, Rita, Banaras, Azra, Aeron-Thomas, John, Hazel, Bath, Maguire, Holly, Veraque, Emelda, Harrison, Louise, Keshvara, Rekha, Cunningham, James, Román, Luis San, Menon, Bijoy K, Blasco, Jordi, Hernández-Pérez, María, Dávalos, Antoni, Majoie, Charles B L M, Campbell, Bruce C V, Guillemin, Francis, Lingsma, Hester, Epstein, Jonathan, Marquering, Henk, Wong, John H, Lopes, Demetrius, Reimann, Gernot, Dippel, Diederik W J, Coutts, Shelagh, du Mesnil de Rochemont, Richard, Yavagal, Dileep, Ferre, Jean Christophe, Roos, Yvo B W E M, Liebeskind, David S, Lenthall, Robert, Molina, Carlos, Al Ajlan, Fahad S, Reddy, Vivek, Dowlatshahi, Dar, Sourour, Nader-Antoine, Oppenheim, Catherine, Mitha, Alim P, Weimar, Christian, van Oostenbrugge, Robert J, Cobo, Erik, Demchuk, Andrew M, Boers, Anna M M, Ford, Gary A, Brown, B Scott, Jovin, Tudor, van Zwam, Wim H, Hill, Michael D, White, Phil, and Bracard, Serge
- Published
- 2018
- Full Text
- View/download PDF
246. Factors Associated with 90-Day Outcomes of Patients with Acute Posterior Circulation Stroke Treated By Mechanical Thrombectomy
- Author
-
Luo, Gang, Mo, Dapeng, Tong, Xu, Liebeskind, David S., Song, Ligang, Ma, Ning, Gao, Feng, Sun, Xuan, Zhang, Xuelei, Wang, Bo, Jia, Baixue, Fernandez-Escobar, Alejandro, and Miao, Zhongrong
- Published
- 2018
- Full Text
- View/download PDF
247. Thrombectomy for Distal, Medium Vessel Occlusions: A Consensus Statement on Present Knowledge and Promising Directions
- Author
-
Saver, Jeffrey L., Chapot, Rene, Agid, Ronit, Hassan, Ameer, Jadhav, Ashutosh P., Liebeskind, David S., Lobotesis, Kyriakos, Meila, Dan, Meyer, Lukas, Raphaeli, Guy, Gupta, Rishi, Amista’, Pietro, Andsberg, Gunnar, Cagnazzo, Federico, Isalberti, Maurizio, Karabegovic, Sanja, Kollia, Kiriaki, Mangiafico, Salvatore, Mis, Marcin, Moreno, Antonio, Mudersbach, Paul von Weitzel, Nossek, Erez, Pero, Guglielmo, Piasecki, Piotr, Raz, Eytan, Reis, Joao, Rudnicka, Svetlana, Sinisalo, Matias, Spinetta, Marco, Stavngaard, Trine, Undren, Per, and Zamaro, Joaquin
- Published
- 2020
- Full Text
- View/download PDF
248. Predictors and Functional Outcomes of Fast, Intermediate, and Slow Progression Among Patients With Acute Ischemic Stroke
- Author
-
Seo, Woo-Keun, Liebeskind, David S., Yoo, Bryan, Sharma, Latisha, Jahan, Reza, Duckwiler, Gary, Tateshima, Satoshi, Nour, May, Szeder, Viktor, Colby, Geoffrey, Starkman, Sidney, Rao, Neal, Bahr Hosseini, Mersedeh, and Saver, Jeffrey L.
- Published
- 2020
- Full Text
- View/download PDF
249. The goldilocks dilemma in acute ischemic stroke.
- Author
-
Tansy, Aaron P and Liebeskind, David S
- Subjects
endovascular ,ischemia ,perfusion ,stroke ,therapy ,Clinical Sciences ,Neurosciences ,Psychology - Abstract
Despite the advent of and exciting advances in novel endovascular therapies, t-PA remains the only proven treatment for acute ischemic stroke to date. Although a variety of reasons likely underlie why past trials of endovascular strategies have been unsuccessful, we address in this perspective piece one critical unknown for which a solution is undoubtedly necessary if future ones are to meet with success: determination and selection of patients that are "just right" for endovascular treatments, or the Goldilocks dilemma. Key clinical criteria highlighted in past trials may help provide a solution to this critical problem. However, for them to do so, we propose that they must be applied in service of a model that accounts for the nuanced, dynamic nature of acute ischemic stroke better than the prevailing "time is brain" model. We provide and examine three clinical cases to illustrate this proposal towards solving the Goldilocks dilemma and advancing treatment in acute ischemic stroke. Further, we address our field's ongoing challenge and mission in the meantime to best care for the "not-so-right" patients, by far the majority of the affected stroke population.
- Published
- 2013
250. Prognostic Evaluation Based on Cortical Vein Score Difference in Stroke
- Author
-
Parthasarathy, Rajsrinivas, Kate, Mahesh, Rempel, Jeremy L, Liebeskind, David S, Jeerakathil, Thomas, Butcher, Kenneth S, and Shuaib, Ashfaq
- Subjects
Biomedical Imaging ,Stroke ,Brain Disorders ,Clinical Research ,Neurosciences ,Adolescent ,Adult ,Aged ,Cerebral Angiography ,Cerebral Veins ,Cerebrovascular Circulation ,Child ,Female ,Humans ,Male ,Middle Aged ,Prognosis ,Tomography ,X-Ray Computed ,angiography ,brain ischemia ,cerebral veins ,collateral circulation ,perfusion ,stroke ,Cardiorespiratory Medicine and Haematology ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
Background and purposeMultimodal imaging in acute ischemic stroke defines the extent of arterial collaterals, resultant penumbra, and associated infarct core, yet limitations abound. We identified superficial and deep venous drainage patterns that predict outcomes in patients with a proximal arterial occlusion of the anterior circulation.MethodsAn observational study that used computed tomography (CT) angiography to detail venous drainage in a consecutive series of patients with a proximal anterior circulation arterial occlusion. The principal veins that drain the cortex (superficial middle cerebral, vein of Trolard, vein of Labbé, and basal vein of Rosenthal) and deep structures were scored with a categorical scale on the basis of degree of contrast enhancement. The Prognostic Evaluation based on Cortical vein score difference In Stroke score encompassing the interhemispheric difference of the composite scores of the veins draining the cortices (superficial middle cerebral+vein of Trolard+vein of Labbé+basal vein of Rosenthal) was analyzed with respect to 90-day modified Rankin Scale outcomes.ResultsThirty-nine patients were included in the study. A Prognostic Evaluation based on Cortical vein score difference In Stroke score of 4 to 8 accurately predicted poor outcomes (modified Rankin Scale, 3-6; odds ratio, 20.53; P
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.